{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:48:19Z","timestamp":1763765299528,"version":"3.41.0"},"reference-count":403,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[1997,6]]},"DOI":"10.1023\/a:1005792206377","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T23:13:52Z","timestamp":1040512432000},"page":"29-66","source":"Crossref","is-referenced-by-count":59,"title":["Molecular and cellular biology of prostate cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"El-Nasir","family":"Lalani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Elie","family":"Laniado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul David","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"126670_CR1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199511233332107","volume":"333","author":"SH Woolf","year":"1995","unstructured":"Woolf SH: Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. [Review]. N Engl J Med 333: 1401\u20131405, 1995","journal-title":"N Engl J Med"},{"key":"126670_CR2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.2910540413","volume":"54","author":"DM Parkin","year":"1993","unstructured":"Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer 54: 594\u2013606, 1993","journal-title":"Int J Cancer"},{"issue":"Suppl2","key":"126670_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000473828","volume":"29","author":"P Boyle","year":"1996","unstructured":"Boyle P, Maisonneuve P, Napalkov P: Incidence of prostate cancer will double by the year 2030: the argument for. Eur Urol 29(Suppl 2): 3\u20139, 1996","journal-title":"Eur Urol"},{"key":"126670_CR4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0277-5379(90)90278-2","volume":"25","author":"OM Jensen","year":"1990","unstructured":"Jensen OM, Esteve J, Moller H, Renard H: Cancer in the European Community and its member states. Eur J Cancer 25: 1167\u20131256, 1990","journal-title":"Eur J Cancer"},{"key":"126670_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.44.1.7","volume":"44","author":"CC Boring","year":"1994","unstructured":"Boring CC, Squires TS, Tong T: Cancer Statistics CA. Cancer J Clin 44: 7\u201326, 1994","journal-title":"Cancer J Clin"},{"key":"126670_CR6","first-page":"3","volume-title":"Questions and Uncertainties about Prostate Cancer","author":"P Boyle","year":"1996","unstructured":"Boyle P, Maisonneuve P, Napalkov P: The threat to health and strategies for control. In: Peeling WB (ed) Questions and Uncertainties about Prostate Cancer, pp. 3\u201329, Oxford: Blackwell Science, 1996"},{"key":"126670_CR7","doi-asserted-by":"crossref","unstructured":"Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics 1996, CA, Cancer J Clin 1996","DOI":"10.3322\/canjclin.46.1.5"},{"key":"126670_CR8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0959-8049(05)80339-9","volume":"29A","author":"FH Schroder","year":"1993","unstructured":"Schroder FH, Boyle P: Screening for prostate cancer \u2014 necessity or nonsense? [Review] Eur J Cancer 29A: 656\u2013661, 1993","journal-title":"Eur J Cancer"},{"key":"126670_CR9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","volume":"273","author":"AL Potosky","year":"1995","unstructured":"Potosky AL, Miller BA, Albertsen PC, Kramer BS: The role of increasing detection in the rising incidence of prostate cancer. JAMA 273: 548\u2013552, 1995","journal-title":"JAMA"},{"key":"126670_CR10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/0003-4819-119-9-199311010-00015","volume":"119","author":"PC Walsh","year":"1993","unstructured":"Walsh PC: Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters [editorial; comment] [see comments]. Ann Intern Med 119: 948\u2013949, 1993","journal-title":"Ann Intern Med"},{"issue":"Suppl2","key":"126670_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000473833","volume":"29","author":"RR Hall","year":"1996","unstructured":"Hall RR: Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against. Eur Urol 29(Suppl 2): 24\u201326, 1996","journal-title":"Eur Urol"},{"key":"126670_CR12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.7326\/0003-4819-119-9-199311010-00009","volume":"119","author":"BS Kramer","year":"1996","unstructured":"Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK: Prostate cancer screening: what we know and what we need to know. Ann Intern Med 119: 914\u2013923, 1996","journal-title":"Ann Intern Med"},{"key":"126670_CR13","first-page":"43","volume":"40","author":"W Haenszel","year":"1996","unstructured":"Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. Natl Cancer Inst Monogr 40: 43\u201368, 1996","journal-title":"Natl Cancer Inst Monogr"},{"key":"126670_CR14","unstructured":"Anonymous: Primer on molecular control of prostate cancer growth. New Jersey: Whitchouse Station, Merck, 1994"},{"key":"126670_CR15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/jnci\/85.19.1571","volume":"85","author":"E Giovannucci","year":"1993","unstructured":"Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WCA: A prospective study of dietary fat and risk of prostate cancer [see comments]. J Natl Cancer Inst 85: 1571\u20131579, 1993","journal-title":"J Natl Cancer Inst"},{"key":"126670_CR16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199404143301501","volume":"330","author":"The alpha-tocopherol, beta-carotene cancer prevention study group.","year":"1994","unstructured":"The alpha-tocopherol, beta-carotene cancer prevention study group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029\u20131035, 1994","journal-title":"N Engl J Med"},{"key":"126670_CR17","first-page":"467","volume":"2","author":"EH Corder","year":"1993","unstructured":"Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N: Vitamin D and prostate cancer: a prediagnostic study with stored sera [see comments]. Cancer Epidemiol Biomarkers Prev 2: 467\u2013472, 1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"126670_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.aje.a116674","volume":"137","author":"H Morrison","year":"1993","unstructured":"Morrison H, Savitz D, Semenciw R, Hulka B, Mao Y, Morison D, Wigle D: Farming and prostate cancer mortality [see comments]. Am J Epidemiol 137: 270\u2013280, 1993","journal-title":"Am J Epidemiol"},{"key":"126670_CR19","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/jnci\/86.22.1718","volume":"86","author":"M Dosemeci","year":"1994","unstructured":"Dosemeci M, Hoover RN, Blair A, Figgs LW, Devesa S, Grauman D, Fraumeni JF Jr: Farming and prostate cancer among African-Americans in the southeastern United States. J Natl Cancer Inst 86: 1718\u20131719, 1994","journal-title":"J Natl Cancer Inst"},{"key":"126670_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/bmj.313.7053.337","volume":"313","author":"A Ekbom","year":"1996","unstructured":"Ekbom A, Hsieh CC, Lipworth L, Wolk A, Ponten J, Adam HO, Trichopoulos D: Perinatal characteristics in relation to incidence of and mortality from prostate cancer. Br Med J 313: 337\u2013341, 1996","journal-title":"Br Med J"},{"key":"126670_CR21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0094-0143(21)01364-1","volume":"17","author":"WF Whitmore Jr","year":"1990","unstructured":"Whitmore WF Jr: Natural history of low-stage prostatic cancer and the impact of early detection. Urol Clin North Am 17: 689\u2013697, 1990","journal-title":"Urol Clin North Am"},{"key":"126670_CR22","first-page":"315","volume":"16","author":"HH Young","year":"1905","unstructured":"Young HH: The early diagnosis and radical cure of carcinoma of the prostate; being a study of 40 cases and presentation of a radical operation which was carried out in 4 cases. Bull Johns Hopkins Hosp 16: 315\u2013318, 1905","journal-title":"Bull Johns Hopkins Hosp"},{"key":"126670_CR23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(94)91109-6","volume":"343","author":"GL Lu-Yao","year":"1994","unstructured":"Lu-Yao GL, Greenberg ER: Changes in prostate cancer incidence and treatment in USA [see comments]. Lancet 343: 251\u2013254, 1994","journal-title":"Lancet"},{"key":"126670_CR24","volume-title":"Urological Oncology","author":"G Williams","year":"1992","unstructured":"Williams G: Radical prostatectomy in localised prostate cancer. In: Waxman J, Williams G (eds) Urological Oncology, London: Edward Arnold, 1992"},{"key":"126670_CR25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ijc.2910200506","volume":"20","author":"N Breslow","year":"1996","unstructured":"Breslow N, Chan CE, Dhom G, Drury RAB, Frank LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H: Latent carcinoma of the prostate at autopsy in 7 areas. Int J Cancer 20: 680\u2013688, 1996","journal-title":"Int J Cancer"},{"key":"126670_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bmj.310.6973.140","volume":"310","author":"FH Schroder","year":"1995","unstructured":"Schroder FH: Detection of prostate cancer [editorial] [see comments]. Br Med J 310: 140\u2013141, 1995","journal-title":"Br Med J"},{"key":"126670_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000478-198901000-00003","volume":"13","author":"AG Ayala","year":"1989","unstructured":"Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ: The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13: 21\u201327, 1989","journal-title":"Am J Surg Pathol"},{"key":"126670_CR28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000478-198808000-00003","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal JE: Normal histology of the prostate. Am J Surg Pathol 12: 619\u2013633, 1988","journal-title":"Am J Surg Pathol"},{"key":"126670_CR29","first-page":"1","volume-title":"Pathology of the Prostate","author":"JE McNeal","year":"1990","unstructured":"McNeal JE, Bostwick DG: Anatomy of the prostate: implications for disease. In: Bostwick DG (ed) Pathology of the Prostate, pp. 1\u201314, New York: Churchill Livingstone, 1990"},{"key":"126670_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/1097-0142(196901)23:1<24::AID-CNCR2820230103>3.0.CO;2-1","volume":"23","author":"JE McNeal","year":"1969","unstructured":"McNeal JE: Origin and development of carcinoma in the prostate. Cancer 23: 24\u201334, 1969","journal-title":"Cancer"},{"key":"126670_CR31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0046-8177(92)90111-F","volume":"23","author":"WC Allsbrook Jr","year":"1992","unstructured":"Allsbrook WC Jr, Simms WW: Histochemistry of the prostate [see comments]. [Review]. Hum Pathol 23: 297\u2013305, 1992","journal-title":"Hum Pathol"},{"key":"126670_CR32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2559.1988.tb02059.x","volume":"13","author":"AS Leong","year":"1988","unstructured":"Leong AS, Gilham P, Milos J: Cytokeratin and vimentin intermediate filament proteins in benign and neoplastic prostatic epithelium. Histopathology 13: 435\u2013442, 1988","journal-title":"Histopathology"},{"key":"126670_CR33","first-page":"735","volume":"144","author":"JA Ruizeveld de Winter","year":"1994","unstructured":"Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-Mooijman MC, Trapman J, Brinkmann AO, Santerse AB, Schroder FH, Van der Kwast TH: Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Patiol 144: 735\u2013746, 1994","journal-title":"Am J Patiol"},{"key":"126670_CR34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/edrv-8-3-338","volume":"8","author":"GR Cunha","year":"1987","unstructured":"Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y: The endocrinology and developmental biology of the prostate. [Review]. Endocr Rev 8: 338\u2013362, 1987","journal-title":"Endocr Rev"},{"key":"126670_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0046-8177(94)90169-4","volume":"25","author":"H Bonkhoff","year":"1994","unstructured":"Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 25: 42\u201346, 1994","journal-title":"Hum Pathol"},{"key":"126670_CR36","first-page":"309","volume":"114","author":"AM Gown","year":"1984","unstructured":"Gown AM, Vogel AM: Monoclonal antibodies to human intermediate filament proteins: distribution of filament proteins in normal human tissues. Am J Pathol 114: 309\u2013321, 1984","journal-title":"Am J Pathol"},{"key":"126670_CR37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00000478-198905000-00006","volume":"13","author":"L Hedrick","year":"1989","unstructured":"Hedrick L, Epstein JI: Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 13: 389\u2013396, 1989","journal-title":"Am J Surg Pathol"},{"key":"126670_CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01600133","volume":"417","author":"FP O'Malley","year":"1990","unstructured":"O'Malley FP, Grignon DJ, Shum DT: Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virchows Arch A Pathol Anat Histopathol 417: 191\u2013196, 1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"126670_CR39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0046-8177(93)90241-8","volume":"24","author":"CE Kramer","year":"1993","unstructured":"Kramer CE, Epstein JI: Nucleoli in low-grade prostate adenocarcinoma and adenosis. Hum Pathol 24: 618\u2013623, 1993","journal-title":"Hum Pathol"},{"key":"126670_CR40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2559.1992.tb01035.x","volume":"20","author":"G Collina","year":"1992","unstructured":"Collina G, Botticelli AR, Martinelli AM, Fano RA, Trentini GP: Sclerosing adenosis of the prostate, Report of 3 cases with electronmicroscopy and immunohistochemical study. Histopathology 20: 505\u2013510, 1992","journal-title":"Histopathology"},{"key":"126670_CR41","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0090-4295(99)80118-6","volume":"45","author":"H Kahane","year":"1995","unstructured":"Kahane H, Sharp JW, Shuman GB, Dasilva G, Epstein JI: Utilization of high molecular weight cytokeratin on prostate needle biopsics in an independent laboratory. Urology 45: 981\u2013986, 1995","journal-title":"Urology"},{"key":"126670_CR42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2559.1988.tb02065.x","volume":"13","author":"AJ Howat","year":"1988","unstructured":"Howat AJ, Mills PM, Lyons TJ, Stephenson TJ: Absence of S-100 protein in prostatic glands. Histopathology 13: 468\u2013470, 1988","journal-title":"Histopathology"},{"key":"126670_CR43","first-page":"957","volume":"136","author":"JR Srigley","year":"1990","unstructured":"Srigley JR, Dardick I, Hartwick RW, Klotz LH: Basal epithelial cells of human prostate gland are not myoepithelial cells. A comparative immunohistochemical and ultrastructural study with human salivary gland. Am J Pathol 136: 957\u2013966, 1990","journal-title":"Am J Pathol"},{"key":"126670_CR44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01605130","volume":"422","author":"H Bonkhoff","year":"1993","unstructured":"Bonkhoff H, Remberger K: Widespread distribution of nuclear androgen receptor in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat Histopathol 422: 35\u201338, 1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"126670_CR45","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0022-5347(17)37389-5","volume":"147","author":"GW Chodak","year":"1992","unstructured":"Chodak GW, Kranc DM, Puy LA, Takeda H, Johnson K, Chang C: Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J Urol 147: 798\u2013803, 1992","journal-title":"J Urol"},{"key":"126670_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-5347(17)35484-8","volume":"150","author":"RJ Cohen","year":"1993","unstructured":"Cohen RJ, Glezerson G, Taylor LF, Grundle HA, Naude JH. The neuroendocrine cell population of the human prostate gland. J Urol 150: 365\u2013368, 1993","journal-title":"J Urol"},{"key":"126670_CR47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/j.1939-4640.1993.tb00389.x","volume":"14","author":"PA Abrahamsson","year":"1993","unstructured":"Abrahamsson PA, di Sant'Agnese PA: Neuroendocrine cells in the human prostate gland. [Review]. J Androl 14: 307\u2013309, 1993","journal-title":"J Androl"},{"key":"126670_CR48","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/1097-0142(19930615)71:12<3952::AID-CNCR2820711226>3.0.CO;2-X","volume":"71","author":"AG Aprikian","year":"1993","unstructured":"Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE: Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 71: 3952\u20133965, 1993","journal-title":"Cancer"},{"key":"126670_CR49","first-page":"607","volume":"109","author":"PA di Sant'Agnese","year":"1985","unstructured":"di Sant'Agnese PA, de Mesy Jensen KL, Churukian CJ, Agarwal MM: Human prostatic endocrine-paracrine (APUD) cells. Distributional analysis with a comparison of serotonin and neuron-specific enolase immunoreactivity and silver stains. Arch Pathol Lab Med 109: 607\u2013612, 1985","journal-title":"Arch Pathol Lab Med"},{"key":"126670_CR50","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-5347(17)38936-X","volume":"142","author":"NS Davis","year":"1989","unstructured":"Davis NS, di Sant'Agnese PA, Ewing JF, Mooney RA: The neuroendocrine prostate: characterization and quantitation of calcitonin in the human gland. J Urol 142: 884\u2013888, 1989","journal-title":"J Urol"},{"key":"126670_CR51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01606893","volume":"423","author":"H Bonkhoff","year":"1993","unstructured":"Bonkhoff H, Stein U, Remberger K: Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch A Pathol Anat Histopathol 423: 291\u2013294, 1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"126670_CR52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00296871","volume":"22","author":"MA Noordzij","year":"1995","unstructured":"Noordzij MA, Van Steenbrugge GJ, Van der Kwast TH, Schroder FH: Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. [Review]. Urol Res 22: 333\u2013341, 1995","journal-title":"Urol Res"},{"key":"126670_CR53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000474168","volume":"30","author":"PA di Sant'Agnese","year":"1996","unstructured":"di Sant'Agnese PA: Neuroendocrine differentiation in the precursors of prostate cancer. Eur Urol 30: 185\u2013190, 1996","journal-title":"Eur Urol"},{"key":"126670_CR54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pros.2990140306","volume":"14","author":"JN Kabalin","year":"1989","unstructured":"Kabalin JN, Peehl DM, Stamcy TA: Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate 14: 251\u2013263, 1989","journal-title":"Prostate"},{"key":"126670_CR55","first-page":"91","volume":"11","author":"LW Chung","year":"1991","unstructured":"Chung LW, Gleave ME, Hsieh JT, Hong SJ, Zhau HE: Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness. [Review]. Cancer Surv 11: 91\u2013121, 1991","journal-title":"Cancer Surv"},{"key":"126670_CR56","first-page":"559","volume":"39","author":"GR Cunha","year":"1993","unstructured":"Cunha GR, Chung LWK, Sannon JM, Taguihi O, Fujii H: Hormone induced morphogenesis and growth: role of mesenchymal interactions. Recent Prog Horm Res 39: 559\u2013598, 1993","journal-title":"Recent Prog Horm Res"},{"key":"126670_CR57","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0022-4731(81)90338-1","volume":"14","author":"GR Cunha","year":"1981","unstructured":"Cunha GR, Chung LWK: Stromal epithelial interaction. Induction of prostate phenotype in urothelium of testicular feminized (TFm\/y) mice. J Steroid Biochem 14: 1317\u20131312, 1981","journal-title":"J Steroid Biochem"},{"key":"126670_CR58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0074-7696(08)60088-1","volume":"47","author":"GR Cunha","year":"1976","unstructured":"Cunha GR: Epithelial stromal interactions in the development of the urogenital tract. Int Rev Cytol 47: 137\u2013194, 1976","journal-title":"Int Rev Cytol"},{"key":"126670_CR59","first-page":"30","volume-title":"Questions and Uncertainties about Prostate Cancer","author":"DG Bostwick","year":"1996","unstructured":"Bostwick DG: Is the behaviour of prostate cancer understood? In: Peeling WB (ed) Questions and Uncertainties about Prostate Cancer, pp. 30\u201349, Oxford: Blackwell Science, 1996"},{"key":"126670_CR60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000474164","volume":"30","author":"DG Bostwick","year":"1996","unstructured":"Bostwick DG: Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 30: 145\u2013152, 1996","journal-title":"Eur Urol"},{"key":"126670_CR61","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00000478-199508000-00002","volume":"19","author":"JI Epstein","year":"1995","unstructured":"Epstein JI, Grignon DJ, Humphrey PA, McNeal JE, Sesterhenn IA, Troncoso P, Wheeler TM: Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 19: 873\u2013886, 1995","journal-title":"Am J Surg Pathol"},{"key":"126670_CR62","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0022-5347(01)65699-4","volume":"156","author":"G Raviv","year":"1996","unstructured":"Raviv G, Janssen T, Zlotta AR, Descamps F, Verhest A, Schulman CC: Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol 156: 1050\u20131055, 1996","journal-title":"J Urol"},{"key":"126670_CR63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4","volume":"70","author":"DG Bostwick","year":"1992","unstructured":"Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP: The association of benign prostatic hyperplasia and cancer of the prostate. [Review]. Cancer 70: 291\u2013301, 1992","journal-title":"Cancer"},{"key":"126670_CR64","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/1097-0142(19950401)75:7+<1823::AID-CNCR2820751612>3.0.CO;2-7","volume":"75","author":"DG Bostwick","year":"1993","unstructured":"Bostwick DG: High grade prostatic intraepithelial neoplasia (PIN), the most likely precursor of prostate cancer. Cancer 75: 1823\u20131836, 1993","journal-title":"Cancer"},{"key":"126670_CR65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5347(17)35487-3","volume":"150","author":"WA Sakr","year":"1993","unstructured":"Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients [see comments]. J Urol 150: 379\u2013385, 1993","journal-title":"J Urol"},{"key":"126670_CR66","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0046-8177(94)90123-6","volume":"25","author":"GB Barctron","year":"1994","unstructured":"Barctron GB, Vogt T, Blasenbreu S, Lohrs U: Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Hum Pathol 25: 506\u2013513, 1994","journal-title":"Hum Pathol"},{"key":"126670_CR67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pros.2990220208","volume":"22","author":"JD Crissman","year":"1993","unstructured":"Crissman JD, Sakr WA, Hussein ME, Pontes JE: DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate. Prostate 22: 155\u2013162, 1993","journal-title":"Prostate"},{"key":"126670_CR68","first-page":"1132","volume":"117","author":"DS Weinberg","year":"1993","unstructured":"Weinberg DS, Weidner N: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma. Arch Pathol Lab Med 117: 1132\u20131137, 1993","journal-title":"Arch Pathol Lab Med"},{"key":"126670_CR69","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2559.1992.tb00400.x","volume":"21","author":"MJ Arends","year":"1992","unstructured":"Arends MJ, Bird CC: Recombinant DNA technology and its diagnostic applications. Histopathology 21: 303\u2013313, 1992","journal-title":"Histopathology"},{"key":"126670_CR70","volume-title":"Molecular biology in histopathology","author":"J Crocker","year":"1994","unstructured":"Crocker J: Molecular biology in histopathology. Chichester: John Wiley and Sons, 1994"},{"key":"126670_CR71","first-page":"553","volume":"2","author":"WW Grody","year":"1989","unstructured":"Grody WW, Gatti RA, Naeim F: Diagnostic molecular pathology. Mod Pathol 2: 553\u2013568, 1989","journal-title":"Mod Pathol"},{"key":"126670_CR72","first-page":"1104","volume":"117","author":"JD Rowley","year":"1993","unstructured":"Rowley JD, Aster JC, Sklar J: The impact of new DNA diagnostic technology on the management of cancer patients. Survey of diagnostic techniques. Arch Pathol Lab Med 117: 1104\u20131109, 1993","journal-title":"Arch Pathol Lab Med"},{"key":"126670_CR73","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0046-8177(85)80147-7","volume":"16","author":"J Sklar","year":"1985","unstructured":"Sklar J: DNA hybridization in diagnostic pathology. Hum Pathol 16: 654\u2013658, 1985","journal-title":"Hum Pathol"},{"key":"126670_CR74","doi-asserted-by":"crossref","unstructured":"Molecular techniques in diagnostic pathology. Hum Pathol 25: 555\u2013614, 1994","DOI":"10.1016\/0046-8177(94)90218-6"},{"key":"126670_CR75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00689787","volume":"12","author":"C Lee","year":"1993","unstructured":"Lee C, Shevrin DH, Kozlowski JM: In vivo and in vitro approaches to study metastasis in human prostatic cancer. [Review]. Cancer Metastasis Rev 12: 21\u201328, 1993","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pros.2990090306","volume":"9","author":"JT Isaacs","year":"1986","unstructured":"Isaacs JT, Isaacs WB, Feitz WW, Scheres J: Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9: 261\u2013281, 1986","journal-title":"Prostate"},{"key":"126670_CR77","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/endo.137.5.8612485","volume":"137","author":"TE Hedlund","year":"1996","unstructured":"Hedlund TE, Moffatt KA, Miller GJ: Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha. 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology 137: 1554\u20131561, 1996","journal-title":"Endocrinology"},{"key":"126670_CR78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3835(95)04071-4","volume":"100","author":"Z Naghashfar","year":"1996","unstructured":"Naghashfar Z, DiPaolo JA, Woodworth CD, Passaniti A: Immortalization of human adult prostatic adenocarcinoma cells by human papilloma virus HPV16 and-18DNA. Cancer Lett 100: 47\u201354, 1996","journal-title":"Cancer Lett"},{"key":"126670_CR79","first-page":"1909","volume":"43","author":"JS Horoszewicz","year":"1983","unstructured":"Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1909\u20131818, 1983","journal-title":"Cancer Res"},{"key":"126670_CR80","first-page":"2157","volume":"56","author":"YS Murakami","year":"1996","unstructured":"Murakami YS, Albertsen H, Brothman AR, Leach RJ, White RL: Suppression of the malignant phenotype of human prostatic cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10. Cancer Res 56: 2157\u20132160, 1996","journal-title":"Cancer Res"},{"key":"126670_CR81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pros.2990240603","volume":"24","author":"KS Hurkadli","year":"1994","unstructured":"Hurkadli KS, Lokeshwar B, Sheth AR, Block NL: Detection of prostatic-inhibin-like peptide in the cytoplasm of LNCaP cells, a human prostatic adenocarcinoma cell line. Prostate 24: 285\u2013290, 1994","journal-title":"Prostate"},{"key":"126670_CR82","first-page":"1807","volume":"54","author":"RS Israeli","year":"1994","unstructured":"Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD: Expression of the prostate-specific membrane antigen. Cancer Res 54: 1807\u20131811, 1994","journal-title":"Cancer Res"},{"key":"126670_CR83","first-page":"13","volume":"47","author":"BJ Furr","year":"1996","unstructured":"Furr BJ, Tucker H: The preclinical development of bicalutamide: pharmacodynamics and mechanism of action Urology 47: 13\u201325; discussion 29\u201332, 1996","journal-title":"The preclinical development of bicalutamide: pharmacodynamics and mechanism of action Urology"},{"key":"126670_CR84","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199505253322101","volume":"332","author":"M-E Taplin","year":"1995","unstructured":"Taplin M-E, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP: Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332: 1393\u20131398, 1995","journal-title":"N Engl J Med"},{"key":"126670_CR85","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00689787","volume":"12","author":"C Lee","year":"1993","unstructured":"Lee C, Shevrin DH, Kozlowski JM: In vivo and in vitro approaches to study metastasis in human prostatic cancer [Review]. Cancer Metastasis Rev 12: 21\u201328, 1993","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR86","first-page":"16","volume":"17","author":"ME Kaighn","year":"1979","unstructured":"Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16\u201323, 1979","journal-title":"Invest Urol"},{"key":"126670_CR87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3835(93)90226-Y","volume":"70","author":"SV Garde","year":"1993","unstructured":"Garde SV, Sheth AR, Porter AT, Pienta KJ: A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate spectic antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 70: 159\u2013166, 1993","journal-title":"Cancer Lett"},{"key":"126670_CR88","first-page":"157","volume":"7","author":"ME Stearns","year":"1995","unstructured":"Stearns ME, Wang M, Stearns M: IL-10 blocks collagen IV invasion by \u2018invasion stimulating factor\u2019 activated PC-3 MI-cells: upregulation of TIMP-1 expression. Oncol Res 7: 157\u2013163, 1995","journal-title":"Oncol Res"},{"key":"126670_CR89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(91)90636-D","volume":"64","author":"JM Bishop","year":"1996","unstructured":"Bishop JM: Molecular themes in oncogenesis. Cell 64: 235\u2013248, 1996","journal-title":"Cell"},{"key":"126670_CR90","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1126\/science.8438152","volume":"259","author":"N Lisitsyn","year":"1993","unstructured":"Lisitsyn N, Wigler M: Cloning the differences between 2 complex genomes. Science 259: 946\u2013951, 1993","journal-title":"Science"},{"key":"126670_CR91","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.7754374","volume":"268","author":"JT Dong","year":"1995","unstructured":"Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884\u2013886, 1995","journal-title":"Science"},{"key":"126670_CR92","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/bjc.1995.439","volume":"72","author":"P Berthon","year":"1995","unstructured":"Berthon P, Dimitrov T, Stower M, Cussenot O, Maitland NJ: A microdissection approach to detect molecular markers during progression of prostate cancer. Br J Cancer 72: 946\u2013951, 1995","journal-title":"Br J Cancer"},{"key":"126670_CR93","volume-title":"PCR protocols, a guide to methods and applications","author":"MA Innis","year":"1990","unstructured":"Innis MA, Gelfand GH, Sninsky JJ, White TJ: PCR protocols, a guide to methods and applications. San Diego, California: Academic Press, 1990"},{"key":"126670_CR94","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0092-8674(78)90278-7","volume":"15","author":"V Jackson","year":"1978","unstructured":"Jackson V: Studies on histone organization in the nucleosome using formaldehyde as a reversible cross-linking agent. Cell 15: 945\u2013954, 1978","journal-title":"Cell"},{"key":"126670_CR95","volume-title":"A practical approach","author":"W Yasui","year":"1992","unstructured":"Yasui W, Ito H, Tahara E: DNA analysis of archival material and its application to tumour pathology. Diagnostic molecular pathology. A practical approach. Oxford: IRL Press, 1992"},{"key":"126670_CR96","volume-title":"A practical approach","author":"M Eisenberg","year":"1992","unstructured":"Eisenberg M, Chimera JA: Human identification by DNA analysis. Diagnostic molecular pathology. A practical approach. Oxford: IRL Press, 1992"},{"key":"126670_CR97","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/0888-7543(89)90129-8","volume":"5","author":"M Orita","year":"1989","unstructured":"Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874\u2013879, 1989","journal-title":"Genomics"},{"key":"126670_CR98","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1073\/pnas.86.8.2766","volume":"86","author":"M Orita","year":"1989","unstructured":"Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766\u20132770, 1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR99","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1073\/pnas.63.2.378","volume":"63","author":"JG Gall","year":"1969","unstructured":"Gall JG, Parduc ML: Formation and detection of RNA-DNA hyrid molecules in cytological preparations. Proc Natl Acad Sci USA 63: 378\u2013383, 1969","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR100","first-page":"69","volume-title":"Principles and Basic Methodology of DNA\/RNA Detection by in situ Hybridization","author":"S Herrington","year":"1992","unstructured":"Herrington S, McGee JO: Diagnostic molecular pathology: A practical approach. In: Herrington CS, McGee JO (eds) Principles and Basic Methodology of DNA\/RNA Detection by in situ Hybridization, pp. 69\u2013102, Oxford: IRL Press, 1992"},{"key":"126670_CR101","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/jnci\/81.24.1852","volume":"81","author":"JM Trent","year":"1989","unstructured":"Trent JM: Clinical correlations of chromosome change in human solid tumors: the tip of the iceberg? J Natl Cancer Inst 81: 1874\u20131878, 1989","journal-title":"J Natl Cancer Inst"},{"key":"126670_CR102","first-page":"1049","volume":"48","author":"AA Sandberg","year":"1988","unstructured":"Sandberg AA, Ture-Carel C, Gemmill RM: Chromosomes in solid tumors and beyond. Cancer Res 48: 1049\u20131059, 1988","journal-title":"Cancer Res"},{"key":"126670_CR103","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/clinchem\/39.4.733","volume":"39","author":"L Morrison","year":"1993","unstructured":"Morrison L, Legator M: Multicolor in situ hybridisation using direct labelled fluorescent probes. Clin Chem 39: 733\u2013734, 1993","journal-title":"Clin Chem"},{"key":"126670_CR104","first-page":"3998","volume":"54","author":"A Alcaraz","year":"1994","unstructured":"Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB: Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54: 3998\u20134002, 1994","journal-title":"Cancer Res"},{"key":"126670_CR105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0076-6879(87)55023-6","volume":"155","author":"KB Mullis","year":"1987","unstructured":"Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155: 335\u2013350, 1987","journal-title":"Methods Enzymol"},{"volume-title":"PCR, A practical approach","year":"1991","key":"126670_CR106","unstructured":"McPherson MJ, Quirke P, Taylor GR (eds): PCR, A practical approach. Oxford: IRL Press, 1991"},{"key":"126670_CR107","first-page":"3795","volume":"50","author":"AR Brothman","year":"1990","unstructured":"Brothman AR, Peehl DM, Patel AM, McNeal JE: Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50: 3795\u20133803, 1990","journal-title":"Cancer Res"},{"key":"126670_CR108","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/gcc.2870080105","volume":"8","author":"H Konig","year":"1993","unstructured":"Konig H, Tenbel W, Van Dongen IW, Hagemeijer A, Romijn JC, Schroder FH: Tissue culture loss of ancuploid cells from carcinomas of the prostate. Genes Chromosom Cancer 8: 22\u201327, 1993","journal-title":"Genes Chromosom Cancer"},{"key":"126670_CR109","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-4608(92)90082-J","volume":"61","author":"MA Micale","year":"1992","unstructured":"Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR: Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability. Cancer Genel Cytogenet 61: 165\u2013173, 1992","journal-title":"Cancer Genel Cytogenet"},{"key":"126670_CR110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/gcc.2870090105","volume":"9","author":"MG Bandyk","year":"1994","unstructured":"Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LW, Liang JC: Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 9: 19\u201327, 1994","journal-title":"Genes Chromosom Cancer"},{"key":"126670_CR111","first-page":"4114","volume":"55","author":"S Takahashi","year":"1995","unstructured":"Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thiobideau SN, Jenkins RB: Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55: 4114\u20134119, 1995","journal-title":"Cancer Res"},{"key":"126670_CR112","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.1073\/pnas.87.22.8751","volume":"87","author":"BS Carter","year":"1990","unstructured":"Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87: 8751\u20138755, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR113","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0888-7543(91)90059-N","volume":"11","author":"K Kunimi","year":"1991","unstructured":"Kunimi K, Bergerheim US, Larsson IL, Ekman P, Collins VP: Allelotyping of human prostatic adenocarcinoma. Genomics 11: 530\u2013536, 1991","journal-title":"Genomics"},{"key":"126670_CR114","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/gcc.2870030308","volume":"3","author":"US Bergerheim","year":"1991","unstructured":"Bergerheim US, Kunimi K, Collins VP, Ekman P: Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3: 215\u2013220, 1991","journal-title":"Genes Chromosom Cancer"},{"key":"126670_CR115","first-page":"3869","volume":"53","author":"GS Bova","year":"1993","unstructured":"Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC et al.: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53: 3869\u20133873, 1993","journal-title":"Cancer Res"},{"key":"126670_CR116","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/gcc.2870100302","volume":"10","author":"D MacGrogan","year":"1994","unstructured":"MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R: Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosom Cancer 10: 151\u2013159, 1994","journal-title":"Genes Chromosom Cancer"},{"key":"126670_CR117","first-page":"3824","volume":"54","author":"JA Macoska","year":"1994","unstructured":"Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE: Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54: 3824\u20133830, 1994","journal-title":"Cancer Res"},{"key":"126670_CR118","first-page":"24111","volume":"56","author":"CD Vocke","year":"1996","unstructured":"Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Srup SE, Duray PH: Analysis of 99 microdissected prostate carcinomas reves a high frequency of allelic loss on chromosome 8p 12\u201321. Cancer Res 56: 24111\u201324126, 1996","journal-title":"Cancer Res"},{"key":"126670_CR119","first-page":"2959","volume":"55","author":"MR Emmert-Buck","year":"1995","unstructured":"Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM: Allelic loss on chromosome 8p12\u201321 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55: 2959\u20132962, 1995","journal-title":"Cancer Res"},{"key":"126670_CR120","first-page":"6061","volume":"54","author":"J Trapman","year":"1994","unstructured":"Trapman J, Sleddens HF, Van der Weiden MM, Dinjens WN, Konig JJ, Schroder FH, Faber PW, Bosman FT: Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54: 6061\u20136064, 1994","journal-title":"Cancer Res"},{"key":"126670_CR121","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000133283","volume":"60","author":"AR Brothman","year":"1992","unstructured":"Brothman AR, Patel AM: Characterization of 10 marker chromosomes in a prostatic cancer cell line by in situ hybridization. Cytogenet Cell Genet 60: 8\u201311, 1992","journal-title":"Cytogenet Cell Genet"},{"key":"126670_CR122","first-page":"2157","volume":"56","author":"YS Murakami","year":"1996","unstructured":"Murakami YS, Albertsen H, Brothman AR, Leach RJ, White RL: Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10. Cancer Res 56: 2157\u20132160, 1996","journal-title":"Cancer Res"},{"key":"126670_CR123","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0046-8177(92)90081-D","volume":"23","author":"AD Deitch","year":"1992","unstructured":"Deitch AD, De Vere White RW: Flow cytometry as a predictive modality in prostate cancer. [Review]. Hum Pathol 23: 352\u2013359, 1992","journal-title":"Hum Pathol"},{"key":"126670_CR124","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF00327068","volume":"5","author":"B Tribukait","year":"1996","unstructured":"Tribukait B: Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms. World J Urol 5: 108\u2013122, 1996","journal-title":"World J Urol"},{"key":"126670_CR125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0046-8177(92)90082-E","volume":"23","author":"UG Falkmer","year":"1992","unstructured":"Falkmer UG: Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma. [Review]. Hum Pathol 23: 360\u2013367, 1992","journal-title":"Hum Pathol"},{"key":"126670_CR126","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/1097-0142(19900815)66:4<752::AID-CNCR2820660426>3.0.CO;2-1","volume":"66","author":"EC Jones","year":"1990","unstructured":"Jones EC, McNeal J, Bruchovsky N, De Jong G: DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases. Cancer 66: 752\u2013757, 1990","journal-title":"Cancer"},{"key":"126670_CR127","first-page":"4682","volume":"49","author":"JL Bos","year":"1989","unstructured":"Bos JL: Ras oncogenes in human prostate: review. Cancer Res 49: 4682\u20134689, 1989","journal-title":"Cancer Res"},{"key":"126670_CR128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2362.1990.tb01848.x","volume":"20","author":"M Barbacid","year":"1990","unstructured":"Barbacid M: Ras oncogenes: their role in neoplasia. Eur J Clin Invest 20: 225\u2013235, 1990","journal-title":"Eur J Clin Invest"},{"key":"126670_CR129","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/1097-0142(19930201)71:3+<1159::AID-CNCR2820711439>3.0.CO;2-U","volume":"71","author":"DM Peehl","year":"1993","unstructured":"Peehl DM: Oncogenes in prostate cancer. An update. [Review]. Cancer 71: 1159\u20131164, 1993","journal-title":"Cancer"},{"key":"126670_CR130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0959-437X(94)90093-0","volume":"4","author":"F McCormick","year":"1994","unstructured":"McCormick F: Activators and effectors of ras p21 proteins. Curr Opin Genet Dev 4: 71\u201376, 1994","journal-title":"Curr Opin Genet Dev"},{"key":"126670_CR131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/07357909309020257","volume":"11","author":"RG Pergolizzi","year":"1993","unstructured":"Pergolizzi RG, Kreis W, Rottach C, Susin M, Broome JD: Mutational status of codons 12 and 13 of the N-and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas [see comments]. Cancer Invest 11: 25\u201332, 1993","journal-title":"Cancer Invest"},{"key":"126670_CR132","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.2990100402","volume":"10","author":"DM Peehl","year":"1987","unstructured":"Peehl DM, Wehner N, Stamey TA: Activated Ki-ras oncogene in human prostatic adenocarcinoma. Prostate 10: 281\u2013289, 1987","journal-title":"Prostate"},{"key":"126670_CR133","first-page":"829","volume":"81","author":"T Tsujii","year":"1990","unstructured":"Tsujii T, Yonese J, Kojima S, Tari K, Ishii M, Seino Y: [The clinical usefulness of urinary basic fetoprotein (BFP) in patients with urological malignancies]. [Japanese]. Nippon Hinyokika Gakkai Zasshi 81: 829\u2013834, 1990","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"126670_CR134","first-page":"1632","volume":"51","author":"PH Gumerlock","year":"1991","unstructured":"Gumerlock PH, Poonamallee UR, Meyers FJ, De Vere White RW: Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res 51: 1632\u20131637, 1991","journal-title":"Cancer Res"},{"key":"126670_CR135","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19920501)69:9<2293::AID-CNCR2820690915>3.0.CO;2-O","volume":"69","author":"N Konishi","year":"1992","unstructured":"Konishi N, Enomoto T, Buzard G, Ohshima M, Ward JM, Rice JM: K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer 69: 2293\u20132299, 1992","journal-title":"Cancer"},{"key":"126670_CR136","first-page":"5991","volume":"52","author":"K Anwar","year":"1992","unstructured":"Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M: Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52: 5991\u20135996, 1992","journal-title":"Cancer Res"},{"key":"126670_CR137","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/gcc.2870050204","volume":"5","author":"T. S. Moul","year":"1992","unstructured":"Moul, Theune SM, Chang EH: Detection of ras mutations in archival testicular germ cell tumours by polymerase chain reaction and oligonucleotide hybridization. Genes Chromosom Cancer 5: 109\u2013118, 1992","journal-title":"Genes Chromosom Cancer"},{"key":"126670_CR138","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1210\/mend-5-2-209","volume":"5","author":"HJ Voeller","year":"1991","unstructured":"Voeller HJ, Wilding G, Gelmann EP: v-rasH expression confers hormone-independent in vitro growth to LNCaP prostate carcinoma cells. Mol Endocrinol 5: 209\u2013216, 1991","journal-title":"Mol Endocrinol"},{"key":"126670_CR139","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0022-5347(17)42131-8","volume":"140","author":"B Treiger","year":"1988","unstructured":"Treiger B, Isaacs J: Expression of a transfected v-Harveyras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. J Urol 140: 1580\u20131586, 1988","journal-title":"J Urol"},{"key":"126670_CR140","first-page":"2042","volume":"48","author":"JA Schalken","year":"1988","unstructured":"Schalken JA, Ebeling SB, Isaacs JT, Treiger B, Bussemakers MJ, de Jon ME, Van de Ven WJ: Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Cancer Res 48: 2042\u20132046, 1988","journal-title":"Cancer Res"},{"key":"126670_CR141","first-page":"6050","volume":"48","author":"AW Partin","year":"1988","unstructured":"Partin AW, Isaacs JT, Treiger B, Coffey DS: Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. Cancer Res 48: 6050\u20136053, 1988","journal-title":"Cancer Res"},{"key":"126670_CR142","first-page":"6830","volume":"50","author":"BS Carter","year":"1990","unstructured":"Carter BS, Epstein JI, Isaacs WB: Ras gene mutations in human prostate cancer. Cancer Res 50: 6830\u20136832, 1990","journal-title":"Cancer Res"},{"key":"126670_CR143","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM198601163140301","volume":"314","author":"MV Viola","year":"1986","unstructured":"Viola MV, Fromowitz E, Oravez S, Deb S, Finkel G, Lundy J, Hand P, Thor A, Schlom J: Expression of ras oncogene p21 in prostate cancer. N Engl J Med 314: 133\u2013137, 1986","journal-title":"N Engl J Med"},{"key":"126670_CR144","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0277-5379(90)90152-J","volume":"26","author":"H Sumiya","year":"1990","unstructured":"Sumiya H, Masai M, Akimoto S, Yatani R, Shimazaki J: Histochemical examination of expression of ras p21 protein and R 1881-binding protein in human prostatic cancers. Eur J Cancer 26: 786\u2013789, 1990","journal-title":"Eur J Cancer"},{"key":"126670_CR145","first-page":"16","volume":"113","author":"VA Vaima","year":"1989","unstructured":"Vaima VA, Austin GE, O'Connell AC: Antibodies to ras oncogene p21 proteins lack immunohistochemical specificity for neoplastic epithelium in human prostate tissue. Arch Pathol Lab Med 113: 16\u201319, 1989","journal-title":"Arch Pathol Lab Med"},{"key":"126670_CR146","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF00184034","volume":"9","author":"MJ Bussemakers","year":"1991","unstructured":"Bussemakers MJ, Isaacs JT, Debruyne FMJ, Van der Ven WJM, Schalken JA: Oncogene expression in prostate cancer. World J Urol 9: 58\u201363, 1991","journal-title":"World J Urol"},{"key":"126670_CR147","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/pros.2990130403","volume":"13","author":"DB Cooke","year":"1988","unstructured":"Cooke DB, Quarmby VE, Petrusz P, Mickey DD, Der CJ, Isaacs JT, French FS: Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system. Prostate 13: 273\u2013287, 1988","journal-title":"Prostate"},{"key":"126670_CR148","first-page":"5914","volume":"10","author":"GJ Kato","year":"1990","unstructured":"Kato GJ, Barret J, Villa Garcia M, Dang C: An amino terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10: 5914\u20135920, 1990","journal-title":"Mol Cell Biol"},{"key":"126670_CR149","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.83.13.4834","volume":"83","author":"C Escort","year":"1986","unstructured":"Escort C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest M, Callahan R: Genetic alterations of the c-myc proto-oncogene in human primary breast carcinoma. Proc Natl Acad Sci USA 83: 4834, 1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR150","first-page":"1535","volume":"46","author":"WH Fleming","year":"1986","unstructured":"Fleming WH, Hamel A, MacDonald R, Ramsey E, Pettigrew NM, Johnston B, Dodd JG, Matusik RJ: Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyporplasia. Cancer Res 46: 1535\u20131538, 1986","journal-title":"Cancer Res"},{"key":"126670_CR151","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000281867","volume":"42","author":"ME Phillips","year":"1987","unstructured":"Phillips ME, Ferro MA, Smith PJ, Davies P: Intranuclear androgen receptor deployment and protooncogene expression in human diseased prostate. Urol Int 42: 115\u2013119, 1987","journal-title":"Urol Int"},{"key":"126670_CR152","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pros.2990110405","volume":"11","author":"R Buttyan","year":"1987","unstructured":"Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA: Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate 11: 327\u2013337, 1987","journal-title":"Prostate"},{"key":"126670_CR153","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pros.2990130402","volume":"13","author":"DB Cooke","year":"1988","unstructured":"Cooke DB, Quarmby VE, Mickey DD, Isaacs JT, French FS: Oncogene expression in prostate cancer: Dunning R3327 rat dorsal prostatic adenocarcinoma system. Prostate 13: 263\u2013272, 1988","journal-title":"Prostate"},{"key":"126670_CR154","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0022-4731(88)90120-3","volume":"30","author":"CL Eaton","year":"1988","unstructured":"Eaton CL, Davies P, Phillips ME: Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem 30: 341\u2013345, 1988","journal-title":"J Steroid Biochem"},{"key":"126670_CR155","first-page":"91","volume":"239","author":"RJ Matusik","year":"1987","unstructured":"Matusik RJ, Fleming WH, Hamel A, Westenbrink TG, Hrabarchuk B, MacDonald R, Ramsey E, Gartner JG, Pettigrew NM, Johnston B et al.: Expression of the c-myc proto-oncogene in prostatic tissue. [Review]. Prog Clin Biol Res 239: 91\u2013112, 1987","journal-title":"Prog Clin Biol Res"},{"key":"126670_CR156","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/00365599109024540","volume":"25","author":"K Funa","year":"1991","unstructured":"Funa K, Nordgren H, Nilsson S: In situ expression of mRNA for proto-oncogenes in benign prostatic hyperplasia and in prostatic carcinoma. Scand J Urol Nephrol 25: 95\u2013100, 1991","journal-title":"Scand J Urol Nephrol"},{"key":"126670_CR157","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(89)90625-9","volume":"56","author":"TC Thompson","year":"1989","unstructured":"Thompson TC, Southgate J, Kitchener G, Land H: Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56: 917\u2013930, 1989","journal-title":"Cell"},{"key":"126670_CR158","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0022-5347(17)40078-4","volume":"143","author":"HB Carter","year":"1990","unstructured":"Carter HB, Piantadosi S, Isaacs JT: Clinical evidence for an implications of the multistep development of prostate cancer. J Urol 143: 742\u2013746, 1990","journal-title":"J Urol"},{"key":"126670_CR159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcb.240390208","volume":"39","author":"NE Hynes","year":"1989","unstructured":"Hynes NE, Gerber HA, Saurer S, Groner B: Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J Cell Biochem 39: 167\u2013173, 1989","journal-title":"J Cell Biochem"},{"key":"126670_CR160","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.2992089","volume":"229","author":"CR King","year":"1985","unstructured":"King CR, Kraus MH, Aaronson SA: Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229: 974\u2013976, 1985","journal-title":"Science"},{"key":"126670_CR161","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235: 177\u2013182, 1987","journal-title":"Science"},{"key":"126670_CR162","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al.: Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707\u2013712, 1989","journal-title":"Science"},{"key":"126670_CR163","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mc.2940050413","volume":"5","author":"HE Zhau","year":"1992","unstructured":"Zhau HE, Wan DS, Zhou J, Miller GJ, von Eschenbach AC: Expression of c-erb B-2\/neu proto-oncogene in human prostatic cancer tissues and cell lines. Mol Carcinog 5: 320\u2013327, 1992","journal-title":"Mol Carcinog"},{"key":"126670_CR164","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0046-8177(91)90159-M","volume":"22","author":"JL Ware","year":"1991","unstructured":"Ware JL, Maygarden SJ, Koontz WW Jr, Strom SC: Immunohistochenmical detection of c-erbB-2 protein in human benign and neoplastic prostate. Hum Pathol 22: 254\u2013258, 1991","journal-title":"Hum Pathol"},{"key":"126670_CR165","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-5347(17)37287-7","volume":"147","author":"K Mellon","year":"1992","unstructured":"Mellon K, Thompson S, Charlton RG, Marsh C, Robinson M, Lane DP, Harris AL, Horne CH, Neal DE: p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol 147: 496\u2013499, 1992","journal-title":"J Urol"},{"key":"126670_CR166","first-page":"643","volume":"5","author":"T Visakorpi","year":"1992","unstructured":"Visakorpi T, Kallioniemi OP, Koivula T, Harvey J, Isola J: Expression of epidermal growth factor receptor and ERBB2 (HER-2\/Neu) oncoprotein in prostatic carcinomas. Mod Pathol 5: 643\u2013648, 1992","journal-title":"Mod Pathol"},{"key":"126670_CR167","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0022-5347(17)35413-7","volume":"150","author":"R Sadasivan","year":"1993","unstructured":"Sadasivan R, Morgan R, Jennings S, Austenfeld M, Van Veldhuizen P, Stephens R, Noble M: Overexpression of Her-2\/neu may be an indicator of poor prognosis in prostate cancer. J Urol 150: 126\u2013131, 1993","journal-title":"J Urol"},{"key":"126670_CR168","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-5347(17)35799-3","volume":"150","author":"EJ Kuhn","year":"1993","unstructured":"Kuhn EJ, Kurnot RA, Sesterhenn IA, Chang EH, Moul JW: Expression of the c-erbB-2 (HER-2\/neu) oncoprotein in human prostatic carcinoma. [Review]. J Urol 150: 1427\u20131433, 1993","journal-title":"J Urol"},{"key":"126670_CR169","first-page":"401A","volume":"143","author":"LH Klotz","year":"1990","unstructured":"Klotz LH, Auger M, Andrulis I, Srigley J: Molecular analysis of neu, sis, c-myc, fos, and P53 oncogenes in benign prostatic hypertrophy and prostatic carcinoma. J Urol 143: 401A, 1990","journal-title":"J Urol"},{"key":"126670_CR170","doi-asserted-by":"crossref","first-page":"294A","DOI":"10.1016\/S0022-5347(17)38318-0","volume":"145","author":"MB Grob","year":"1991","unstructured":"Grob MB, Schellhammer PF, Wright GL et al.: Expression of the c-erbB2 oncogene in human prostatic carcinoma. J Urol 145: 294A, 1991","journal-title":"J Urol"},{"key":"126670_CR171","first-page":"113","volume":"239","author":"RG Smith","year":"1987","unstructured":"Smith RG, Nag AL: Regulation of c-sis expression in tumors of the male reproductive tract. [Review]. Prog Clin Biol Res 239: 113\u2013122, 1987","journal-title":"Prog Clin Biol Res"},{"key":"126670_CR172","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0006-291X(85)91168-4","volume":"132","author":"AW Rijnders","year":"1985","unstructured":"Rijnders AW, Van der Korput JA, Van Steenbrugge GJ, Romijn JC, Trapman J: Expression of cellular oncogenes in human prostatic carcinoma cell lines Biochem Biophys Res Commun 132: 548\u2013554, 1985","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl2","key":"126670_CR173","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00000421-198801102-00002","volume":"11","author":"P Davies","year":"1988","unstructured":"Davies P, Eaton CL, France TD, Phillips ME: Growth factor receptors and oncogene expression in prostate cells. [Review]. Am J Clin Oncol 11Suppl 2: S1\u20137, 1988","journal-title":"Am J Clin Oncol"},{"key":"126670_CR174","first-page":"221A","volume":"149","author":"TJ McDonnell","year":"1993","unstructured":"McDonnell TJ, Troncoso P, Brisbay SM, Logothetis CJ, Chung LK, Hsieh JT: Bel-2 expression in androgen-independent prostate carcinoma. J Urol 149: 221A, 1993","journal-title":"J Urol"},{"key":"126670_CR175","first-page":"4438","volume":"55","author":"AJ Raffo","year":"1995","unstructured":"Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R: Overexpression of bel-z protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 55: 4438\u20134445, 1995","journal-title":"Cancer Res"},{"key":"126670_CR176","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein BA: A genetic model for colorectal tumorigenesis. Cell 61: 759\u2013769, 1990","journal-title":"Cell"},{"key":"126670_CR177","first-page":"585","volume":"60","author":"TA Seemayer","year":"1989","unstructured":"Seemayer TA, Cavenee WK: Biology of disease: molecular mechanisms of oncogenesis. Lab Invest 60: 585\u2013599, 1989","journal-title":"Lab Invest"},{"key":"126670_CR178","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0092-8674(91)90641-B","volume":"64","author":"CJ Marshall","year":"1991","unstructured":"Marshall CJ: Tumor suppressor genes. Cell 64: 313\u2013326, 1991","journal-title":"Cell"},{"key":"126670_CR179","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1126\/science.1659741","volume":"254","author":"RA Weinberg","year":"1991","unstructured":"Weinberg RA: Tumor suppressor genes. Science 254: 249\u2013270, 1991","journal-title":"Science"},{"key":"126670_CR180","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0094-0143(21)00911-3","volume":"20","author":"NA Romas","year":"1993","unstructured":"Romas NA, Kwan DJ: Prostatic acid phosphatase. Biomolecular features and assays for serum determination. [Review]. Urol Clin North Am 20: 581\u2013588, 1993","journal-title":"Urol Clin North Am"},{"key":"126670_CR181","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/342705a0","volume":"342","author":"JM Nigro","year":"1989","unstructured":"Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P et al.: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705\u2013708, 1989","journal-title":"Nature"},{"key":"126670_CR182","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. [Review]. Science 253: 49\u201353, 1991","journal-title":"Science"},{"key":"126670_CR183","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni J Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233\u20131238, 1990","journal-title":"Science"},{"key":"126670_CR184","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1172\/JCI116034","volume":"90","author":"T Frebourg","year":"1992","unstructured":"Frebourg T, Friend SH: Cancer risks from germ-line p53 mutations. J Clin Invest 90: 1637\u20131641, 1992","journal-title":"J Clin Invest"},{"key":"126670_CR185","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.84.24.9059","volume":"84","author":"SH Friend","year":"1987","unstructured":"Friend SH, Horowitz JM, Gerber MR, Wang XF, Bogenmann E, Li FP, Weinberg RA: Deletions of a DNA sequence in retinoblastomas and mesenchymal inmors organization of the sequence and its encoded protein [publied erratum appears in Proc Natl Acad Sci USA 1988 Apr; 85 (7): 2234]. Proc Natl Acad Sci USA 84: 9059\u20139063, 1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR186","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0046-8177(88)80504-5","volume":"19","author":"AE Mendoza","year":"1988","unstructured":"Mendoza AE, Shew JY, Lee EY, Bookstein R, Lee WH: A case of synovial sarcoma with abnormal expression of the human retinoblastoma susceptibility gene. Hum Pathol 19: 487\u2013489, 1988","journal-title":"Hum Pathol"},{"key":"126670_CR187","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.2838909","volume":"241","author":"JW Harbour","year":"1988","unstructured":"Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241: 353\u2013357, 1988","journal-title":"Science"},{"key":"126670_CR188","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.3175651","volume":"242","author":"A T'Ang","year":"1988","unstructured":"T'Ang A, Varley JM, Chakraborty S, Murphree AL, Fung YK: Structural rearrangement of the retinoblastoma gene in human breast carcinoma., Science 242: 263\u2013266, 1988","journal-title":"Science"},{"key":"126670_CR189","first-page":"471","volume":"3","author":"J Yokota","year":"1988","unstructured":"Yokota J, Akiyama T, Fung YK, Benediet WF, Namba Y, Hanaoka M, Wada M, Terasaki T, Shimosato Y, Sugimura T et al.: Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3: 471\u2013475, 1988","journal-title":"Oncogene"},{"key":"126670_CR190","first-page":"725","volume":"4","author":"JM Varley","year":"1989","unstructured":"Varley JM, Armour J, Swallow JE, Jeffreys AJ, Ponder BA, T'Ang A, Fung YK, Brammar WJ, Walker RA: The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours [published erratum appears in Oncogene 1990 Feb: 5 (2): 245]. Oncogene 4: 725\u2013729, 1989","journal-title":"Oncogene"},{"key":"126670_CR191","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.2300823","volume":"247","author":"R Bookstein","year":"1990","unstructured":"Bookstein R, Shew JY, Chen PL, Scully P, Lee WH: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247: 712\u2013715, 1990","journal-title":"Science"},{"key":"126670_CR192","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1073\/pnas.87.19.7762","volume":"87","author":"R Bookstein","year":"1990","unstructured":"Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee WH: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762\u20137766, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR193","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pros.2990260108","volume":"26","author":"JD Brooks","year":"1995","unstructured":"Brooks JD, Bova GS, Isaacs WB: Allelic loss of the retinoblastoma gene in primary human prostatic adenocarci nomas. Prostate 26: 35\u201339, 1995","journal-title":"Prostate"},{"key":"126670_CR194","first-page":"181","volume":"1155","author":"LA Donehower","year":"1993","unstructured":"Donehower LA, Bradeley A: The tumor suppressor gene p53, Biochim Biophys Acta 1155: 181\u2013205, 1993","journal-title":"Biochim Biophys Acta"},{"key":"126670_CR195","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.bi.62.070193.003203","volume":"621","author":"AJ Levine","year":"1993","unstructured":"Levine AJ: The TSGs. Ann Rev Biochem 621: 623\u2013651, 1993","journal-title":"Ann Rev Biochem"},{"key":"126670_CR196","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","volume":"329","author":"CC Harris","year":"1993","unstructured":"Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene [see comments]. [Review]. N Engl J Med 329: 1318\u20131327, 1993","journal-title":"N Engl J Med"},{"key":"126670_CR197","first-page":"1775","volume":"6","author":"T Takahashi","year":"1991","unstructured":"Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y, Ueda R: The p53 gene is very frequently mutated in small-cell lung cancer with a distinet nucleotide substitution pattern. Oncogene 6: 1775\u20131778, 1991","journal-title":"Oncogene"},{"key":"126670_CR198","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.2024123","volume":"252","author":"D Sidransky","year":"1991","unstructured":"Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P et al.: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706\u2013709, 1991","journal-title":"Science"},{"key":"126670_CR199","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jnci\/84.11.883","volume":"84","author":"T Visakorpi","year":"1992","unstructured":"Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J: Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 84: 883\u2013887, 1992","journal-title":"J Natl Cancer Inst"},{"key":"126670_CR200","first-page":"3369","volume":"53","author":"R Bookstein","year":"1993","unstructured":"Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC: p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 53: 3369\u20133373, 1993","journal-title":"Cancer Res"},{"key":"126670_CR201","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ijc.2910560504","volume":"56","author":"WN Dinjens","year":"1994","unstructured":"Dinjens WN, Van der Weiden MM, Schroeder FH, Bosman FT, Trapman J: Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int J Cancer 56: 630\u2013633, 1994","journal-title":"Int J Cancer"},{"key":"126670_CR202","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5347(17)35000-0","volume":"151","author":"HJ Voeller","year":"1994","unstructured":"Voeller HJ, Sugars LY, Pretlow T, Gelmann EP: p53 oncogene mutations in human prostate cancer specimens. J Urol 151: 492\u2013495, 1994","journal-title":"J Urol"},{"key":"126670_CR203","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/jnci\/85.20.1657","volume":"85","author":"NM Navone","year":"1993","unstructured":"Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ: p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85: 1657\u20131669, 1993","journal-title":"J Natl Cancer Inst"},{"key":"126670_CR204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-5347(17)35458-7","volume":"150","author":"PJ Effert","year":"1993","unstructured":"Effert PJ, McCoy RH, Walther PJ, Liu ET: p53 gene alterations in human prostate carcinoma. J Urol 150: 257\u2013261, 1993","journal-title":"J Urol"},{"key":"126670_CR205","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0022-5347(17)35231-X","volume":"151","author":"AG Aprikian","year":"1994","unstructured":"Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z, Cordon-Cardo C: Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol 151: 1276\u20131280, 1994","journal-title":"J Urol"},{"key":"126670_CR206","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240: 889\u2013895, 1988","journal-title":"Science"},{"key":"126670_CR207","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0960-0760(91)90201-F","volume":"40","author":"AO Brinkmann","year":"1991","unstructured":"Brinkmann AO, Kuiper GG, Ris-Stalpers C, Van Rooij HC, Romalo G, Trifiro M, Mulder E, Pinsky L, Schweikert HU, Trapman J: Androgen receptor abnormalities. [Review]. J Steroid Biochem Mol Biol 40: 349\u2013352, 1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"126670_CR208","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.1016\/S0021-9258(18)98349-3","volume":"268","author":"PW Faber","year":"1993","unstructured":"Faber PW, Van Rooij HCJ, Schipper HP, Brinkmann AO, Trapman J: Two different, overlapping pathways of transcription initiation are active on the TAT-less human androgen receptor promoter. J Biol Chem 268: 9296\u20139301, 1993","journal-title":"J Biol Chem"},{"key":"126670_CR209","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1210\/mend-4-5-708","volume":"4","author":"SE Rundlett","year":"1990","unstructured":"Rundlett SE, Wu XP, Miesfeld RL: Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. Mol Endocrinol 4: 708\u2013714, 1990","journal-title":"Mol Endocrinol"},{"key":"126670_CR210","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1210\/mend-5-10-1396","volume":"5","author":"G Jenster","year":"1991","unstructured":"Jenster G, Van der Korput HA, Van Vroonhoven C, Van der Kwast TH, Trapman J, Brinkmann AO: Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization, Mol Endocrinol 5: 1396\u20131404, 1991","journal-title":"Mol Endocrinol"},{"key":"126670_CR211","first-page":"497","volume":"352","author":"BF Luisi","year":"1991","unstructured":"Luisi BF, Xu WX, Otwinowski Z, Feedman LP, Yamamoto KR, Sigler PB: Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA Nature 352: 497\u2013505, 1991","journal-title":"Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA Nature"},{"key":"126670_CR212","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1091\/mbc.1.3.291","volume":"1","author":"D Picard","year":"1990","unstructured":"Picard D, Kumar V, Chambon P, Yamamoto KR: Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul 1: 291\u2013299, 1990","journal-title":"Cell Regul"},{"key":"126670_CR213","first-page":"5382","volume":"50","author":"WD Tilley","year":"1990","unstructured":"Tilley WD, Wilson CM, Marcelli M, McPhaul MJ: Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 50: 5382\u20135386, 1990","journal-title":"Cancer Res"},{"key":"126670_CR214","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","volume":"9","author":"T Visakorpi","year":"1995","unstructured":"Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R. Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9: 401\u2013406, 1995","journal-title":"Nat Genet"},{"key":"126670_CR215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00184245","volume":"12","author":"H Klocker","year":"1994","unstructured":"Klocker H, Culig Z, Kaspar F, Hobisch A, Eberle J, Reissigl A, Bartsch G: Androgen signal transduction and prostatic carcinoma. [Review]. World J Urol 12: 99\u2013103, 1994","journal-title":"World J Urol"},{"key":"126670_CR216","first-page":"1107","volume":"43","author":"ER Barrack","year":"1983","unstructured":"Barrack ER, Bujnovsky P, Walsh PC: Subcellular distribution of androgen receptors in benign hyperplastic and malignant prostatic tissues: characterisation of salt resistant receptors. Cancer Res 43: 1107\u20131116, 1983","journal-title":"Cancer Res"},{"key":"126670_CR217","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/pros.2990080408","volume":"8","author":"N Kyprianou","year":"1986","unstructured":"Kyprianou N, Davies P: Association states of androgen receptor nuclei of human benign hypertrophic prostate. Prostate 8: 363\u2013380, 1986","journal-title":"Prostate"},{"key":"126670_CR218","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/pros.2990180207","volume":"18","author":"P Ekman","year":"1991","unstructured":"Ekman P, Brolin J: Steroid receptor profile in human prostate cancer metastases as compared with primary prostatic carcinoma. Prostate 18: 147\u2013153, 1991","journal-title":"Prostate"},{"key":"126670_CR219","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pros.2990170405","volume":"17","author":"M Masai","year":"1990","unstructured":"Masai M, Sumiya H, Akimoto S, Yatani R, Chang CS, Liao SS, Shimazaki J: Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 17: 293\u2013300, 1990","journal-title":"Prostate"},{"key":"126670_CR220","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0960-0760(93)90316-O","volume":"46","author":"H Suzuki","year":"1993","unstructured":"Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J: Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46: 759\u2013765, 1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"126670_CR221","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1073\/pnas.89.14.6319","volume":"89","author":"JR Newmark","year":"1992","unstructured":"Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, Barrack ER: Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci USA 89: 6319\u20136323, 1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR222","first-page":"2861","volume":"54","author":"JP Gaddipati","year":"1994","unstructured":"Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S: Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 54: 2861\u20132864, 1994","journal-title":"Cancer Res"},{"key":"126670_CR223","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0888-7543(92)90371-X","volume":"12","author":"A Edwards","year":"1992","unstructured":"Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R: Genetic variation of five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12: 241\u2013253, 1992","journal-title":"Genomics"},{"key":"126670_CR224","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/2.3.273","volume":"2","author":"HF Sloddens","year":"1993","unstructured":"Sloddens HF, Oostra BA, Brinkmann AO et al.: Tyrinucleotide (GGN) repeat polymorphism in the human androgen receptor. Hum Mol Genet 2: 273, 1993","journal-title":"Hum Mol Genet"},{"key":"126670_CR225","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","volume":"22","author":"NL Chamberlin","year":"1994","unstructured":"Chamberlin NL, Driver ED, Miesfield RL: The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain effect transactivation function. Nucleic Acids Res 22: 3181\u20133186, 1994","journal-title":"Nucleic Acids Res"},{"key":"126670_CR226","first-page":"1937","volume":"55","author":"RA Irvine","year":"1995","unstructured":"Irvine RA, Yu MC, Ross RK, Coetzee GA: The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55: 1937\u20131940, 1995","journal-title":"Cancer Res"},{"key":"126670_CR227","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/bbrc.1994.1011","volume":"198","author":"MP Schoenberg","year":"1994","unstructured":"Schoenberg MP, Hakimi JM, Wang S, Bova GS, Epstein JI, Fischbeck KH, Isaacs WB, Walsh PC, Barrack ER: Microsatellite mutation (CAG24\u219218) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 198: 74\u201380, 1994","journal-title":"Biochem Biophys Res Commun"},{"key":"126670_CR228","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1464-410X.1996.09721.x","volume":"77","author":"RL Byrne","year":"1996","unstructured":"Byrne RL, Leung H, Neal DE: Peptide growth factors in the prostate as mediators of stromal epithelial interactions. Br J Urol 77: 627\u2013633, 1996","journal-title":"Br J Urol"},{"key":"126670_CR229","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0305-7372(95)90038-1","volume":"21","author":"P Norgaard","year":"1995","unstructured":"Norgaard P, Hougaard S, Poulsen HS, Spang-Thomsen M: Transforming growth factor beta and cancer. [Review], Cancer Treat Rev 21: 367\u2013403, 1995","journal-title":"Cancer Treat Rev"},{"key":"126670_CR230","first-page":"44","volume":"56","author":"IY Kim","year":"1996","unstructured":"Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C: Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res 56: 44\u201348, 1996","journal-title":"Cancer Res"},{"key":"126670_CR231","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0022-5347(17)38034-5","volume":"146","author":"D Goldstein","year":"1991","unstructured":"Goldstein D, O'Leary M, Mitchen J, Borden EC, Wilding G: Effects of interferon beta ser and transforming growth factor beta on prostatic cell ines. J Urol 146: 1173\u20131177, 1991","journal-title":"J Urol"},{"key":"126670_CR232","first-page":"4952","volume":"11","author":"A Zentella","year":"1991","unstructured":"Zentella A, Weis FM, Ralph DA, Laiho M, Massague J: Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function. Mol Cell Biol 11: 4952\u20134958, 1991","journal-title":"Mol Cell Biol"},{"key":"126670_CR233","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0046-8177(93)90055-L","volume":"24","author":"LD Truong","year":"1993","unstructured":"Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC: Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. Hum Pathol 24: 4\u20139, 1993","journal-title":"Hum Pathol"},{"key":"126670_CR234","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0495-282","volume":"1","author":"V Ivanovic","year":"1995","unstructured":"Ivanovic V, Mclman A, Davis-Joseph B, Valcic M, Geliebter J: Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer [letter]. Nature Med 1: 282\u2013284, 1995","journal-title":"Nature Med"},{"key":"126670_CR235","first-page":"2596","volume":"55","author":"DM Morton","year":"1995","unstructured":"Morton DM, Barrack ER: Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res 55: 2596\u20132602, 1995","journal-title":"Cancer Res"},{"key":"126670_CR236","first-page":"15","volume":"6","author":"MS Steiner","year":"1992","unstructured":"Steiner MS, Barrack ER: Transforming growth factor-beta 1 overproduction in prostate cancer effects on growth in vivo and in vitro. Mol Endocrinol 6: 15\u201325, 1992","journal-title":"Mol Endocrinol"},{"key":"126670_CR237","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0303-7207(89)90115-9","volume":"62","author":"G Wilding","year":"1989","unstructured":"Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E: Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Mol Cell Endocrinol 62: 79\u201387, 1989","journal-title":"Mol Cell Endocrinol"},{"key":"126670_CR238","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<796::AID-IJC15>3.0.CO;2-1","volume":"66","author":"G.R.E Desruisseau","year":"1996","unstructured":"Desruisseau, Ghazarossian Ragni E, Chinot O, Martin PM: Divergent effect of TGFbetal on growth and proteolytic modulation of human prostatic cancer cell lines. Intern J Cancer 66: 796\u2013801, 1996","journal-title":"Intern J Cancer"},{"key":"126670_CR239","first-page":"1142","volume":"56","author":"KA Cooney","year":"1996","unstructured":"Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ: Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56: 1142\u20131145, 1996","journal-title":"Cancer Res"},{"key":"126670_CR240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/172460089200700104","volume":"7","author":"SN Lloyd","year":"1992","unstructured":"Lloyd SN, Brown LL, Leake RE: Transforming growth factor-alpha expression in benign and malignant human prostatic discase. Int J Biol Markers 7: 27\u201334, 1992","journal-title":"Int J Biol Markers"},{"key":"126670_CR241","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00925693","volume":"126","author":"KZ Ching","year":"1993","unstructured":"Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG: Expression of mRNA for cpidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126: 151\u2013158, 1993","journal-title":"Mol Cell Biochem"},{"key":"126670_CR242","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0022-5347(17)40253-9","volume":"143","author":"GL Morris","year":"1990","unstructured":"Morris GL, Dodd JG: Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143: 1272\u20131274, 1990","journal-title":"J Urol"},{"key":"126670_CR243","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1464-410X.1994.tb16589.x","volume":"74","author":"SB Fox","year":"1994","unstructured":"Fox SB, Persad RA, Colcman N, Day CA, Silcocks PB, Collins CC: Prognostic value of c-crbB-2 and epidermal growth factor receptor in stage Al (Tla) prostatic adenocarcinoma. Br J Urol 74: 214\u2013220, 1994","journal-title":"Br J Urol"},{"key":"126670_CR244","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.2990150211","volume":"15","author":"JM Connolly","year":"1989","unstructured":"Connolly JM, Rose DP: Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate 15: 177\u2013186, 1989","journal-title":"Prostate"},{"key":"126670_CR245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pros.2990190210","volume":"19","author":"JM Connolly","year":"1991","unstructured":"Connolly JM, Rose DP: Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19: 173\u2013180, 1991","journal-title":"Prostate"},{"key":"126670_CR246","first-page":"2780","volume":"51","author":"DR Hofer","year":"1991","unstructured":"Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM: Autonomous growth of androgenindependent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res 51: 2780\u20132785, 1991","journal-title":"Cancer Res"},{"key":"126670_CR247","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pros.2990160304","volume":"16","author":"JM Connolly","year":"1990","unstructured":"Connolly JM, Rose DP: Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16: 209\u2013218, 1990","journal-title":"Prostate"},{"key":"126670_CR248","first-page":"1472","volume":"77","author":"XH Liu","year":"1993","unstructured":"Liu XH, Wiley HS, Meikle AW: Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)\/TGF-alpha receptor. J Clin Endocrinol Metah 77: 1472\u20131478, 1993","journal-title":"J Clin Endocrinol Metah"},{"key":"126670_CR249","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pros.2990120108","volume":"12","author":"AL Schuurmans","year":"1988","unstructured":"Schuurmans AL, Bolt J, Mulder E: Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP. Prostate 12: 55\u201363, 1988","journal-title":"Prostate"},{"key":"126670_CR250","first-page":"3197","volume":"55","author":"A. B. Brass","year":"1995","unstructured":"Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB: Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Cancer Res 55: 3197\u20133203, 1995","journal-title":"Cancer Res"},{"key":"126670_CR251","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF00118180","volume":"13","author":"H Xie","year":"1995","unstructured":"Xie H, Turner T, Wang MH, Singh RK, Siegal GP, Wells A: In vitro invasiveness of DU-145 human prostate carcinoma cells is modelated by EGF receptor-mediated signals. Clin Exp Metastasis 13: 407\u2013419, 1995","journal-title":"Clin Exp Metastasis"},{"key":"126670_CR252","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pros.2990270506","volume":"27","author":"DF Liu","year":"1995","unstructured":"Liu DF, Rabbani SA: Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3. Prostate 27: 269\u2013276, 1995","journal-title":"Prostate"},{"key":"126670_CR253","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/pros.2990240110","volume":"24","author":"DF Jarrard","year":"1994","unstructured":"Jarrard DF, Blitz BF, Smith RC, Patai BL, Rukstalis DB: Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion. Prostate 24: 46\u201353, 1994","journal-title":"Prostate"},{"key":"126670_CR254","first-page":"169","volume":"54","author":"J Pinski","year":"1994","unstructured":"Pinski J, Reile H, Halmos G, Groot K, Schally AV: Inhibitory effects of somatostatin analogue RC-160 and bombesin\/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen independent Dunning R-3327-AT-1 rat prostate cancer. Cancer Res 54: 169\u2013174, 1994","journal-title":"Cancer Res"},{"key":"126670_CR255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijc.2910590112","volume":"59","author":"J Pinski","year":"1994","unstructured":"Pinski J, Reile H, Halmos G, Groot K, Schally AV: Inhibitory effects of analogs of utcinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Int J Cancer 59: 51\u201355, 1994","journal-title":"Int J Cancer"},{"key":"126670_CR256","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-5347(17)37747-9","volume":"146","author":"JH Kim","year":"1991","unstructured":"Kim JH, Sherwood ER. Sutkowski DM, Lee C, Kozlowski JM: Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution. J Urol 146: 171\u2013176, 1991","journal-title":"J Urol"},{"key":"126670_CR257","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2007-1000777","volume":"26","author":"P Cohen","year":"1994","unstructured":"Cohen P, Pechl DM, Rosenfeld RG: The IGF axis in the prostate, [Review]. Horm Metab Res 26: 81\u201384, 1994","journal-title":"Horm Metab Res"},{"key":"126670_CR258","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/08977199109104819","volume":"4","author":"EK Kaicer","year":"1991","unstructured":"Kaicer EK, Blat C, Harel L: IGF-I and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors 4: 231\u2013237, 1991","journal-title":"Growth Factors"},{"key":"126670_CR259","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pros.2990220307","volume":"22","author":"M Iwamura","year":"1993","unstructured":"Iwamura M, Sluss PM, Casamento JB, Cockett AT: Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 22: 243\u2013252. 1993","journal-title":"Prostate"},{"key":"126670_CR260","first-page":"1102","volume":"53","author":"Z Pietrzkowski","year":"1993","unstructured":"Pietrzkowski Z, Mudholland G, Gomella L, Jameson BA, Wernicke D, Baserga R: Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res 53: 1102\u20131106, 1993","journal-title":"Cancer Res"},{"key":"126670_CR261","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/pros.2990190405","volume":"19","author":"C Polychronakos","year":"1991","unstructured":"Polychronakos C, Janthly U, Lehoux JF, Koutsilieris M: Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells:characterization of the receptors involved. Prostate 19: 313\u2013321, 1991","journal-title":"Prostate"},{"key":"126670_CR262","first-page":"5474","volume":"54","author":"Z Culig","year":"1994","unstructured":"Culig Z, Hobich A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H: Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54: 5474\u20135478, 1994","journal-title":"Cancer Res"},{"key":"126670_CR263","first-page":"905","volume":"12","author":"M Koutsilieris","year":"1992","unstructured":"Koutsilieris M, Polychronakos C: Proteinolytic activity against IGF-binding proteins involved in the paracrine interactions between prostate adenocarcinoma cells and os teoblasts. Anticancer Res 12: 905\u2013910, 1992","journal-title":"Anticancer Res"},{"key":"126670_CR264","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/pros.2990270507","volume":"27","author":"T Janssen","year":"1995","unstructured":"Janssen T, Kiss R, Dedecker R, Petein M, Pasteels JL, Schulman C: Influence of dihydrotestosterone, epidermal growth factor, and basic fibroblast growth factor on the cell kinetics of the PC3, DU145, and LNCaP prostatic cancer cell lines: relationship with DNA ploidy level. Prostate 27: 277\u2013286, 1995","journal-title":"Prostate"},{"key":"126670_CR265","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0022-5347(17)37506-7","volume":"147","author":"ME Gleave","year":"1992","unstructured":"Gleave ME, Hsieh JT, von Eschenbach AC, Chung LW: Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumorstromal cell interaction in prostate carcinoma growth and metastasis. J Urol 147: 1151\u20131159, 1992","journal-title":"J Urol"},{"key":"126670_CR266","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm0995-944","volume":"1","author":"JB Nelson","year":"1995","unstructured":"Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW: Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nature Med 1: 944\u2013949, 1995","journal-title":"Nature Med"},{"key":"126670_CR267","first-page":"663","volume":"56","author":"JB Nelson","year":"1996","unstructured":"Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TH, Bova GS, Simons JW: Endothelin-1 production and decreased endothin B receptor expression in advanced prostate cancer. Cancer Res 56: 663\u2013668. 1996","journal-title":"Cancer Res"},{"key":"126670_CR268","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-5347(17)35083-8","volume":"151","author":"S Kobayashi","year":"1994","unstructured":"Kobayashi S, Tang R, Wang B, Opgenorth T, Stein E, Shapiro E, Lepor H: Localization of endothelin receptors in the human prostate. J Urol 151: 763\u2013766, 1994","journal-title":"J Urol"},{"key":"126670_CR269","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(89)90167-2","volume":"159","author":"TD Warner","year":"1989","unstructured":"Warner TD, de Nucci G, Vane JR: Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 159: 325\u2013326, 1989","journal-title":"Eur J Pharmacol"},{"key":"126670_CR270","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI116338","volume":"91","author":"Y Hirata","year":"1993","unstructured":"Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F: Endothelin receptor subtype B mediates the synthesis of nitric oxide by bovine endothelial cells. J Clin Invest 91: 1367\u20131373, 1993","journal-title":"J Clin Invest"},{"key":"126670_CR271","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/bbrc.1994.2451","volume":"203","author":"I Kitasjima","year":"1994","unstructured":"Kitasjima I, Kawahara K, Nakajima T, Sockima Y, Matsuyama T, Marnyama I: Nitric oxide-mediated apoptosis in mastocytoma. Biochem Biophys Res Commun 203: 244\u2013251, 1994","journal-title":"Biochem Biophys Res Commun"},{"key":"126670_CR272","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.181.4.1333","volume":"181","author":"K Xie","year":"1995","unstructured":"Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C, Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses the tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333\u20131343, 1995","journal-title":"J Exp Med"},{"key":"126670_CR273","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcp.1041580313","volume":"158","author":"MS Goligorsky","year":"1994","unstructured":"Goligorsky MS, Tsukahara H, Magazine H, Anderson TT, Malik AB, Bahou WF: Termination of endothelin signalling: role of nitric oxide. J Cell Physiol 158: 485\u2013494, 1994","journal-title":"J Cell Physiol"},{"key":"126670_CR274","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1172\/JCI114477","volume":"85","author":"C Boulanger","year":"1990","unstructured":"Boulanger C, Luscher TF: Release of endothelin from the porcine aorta: inhibition by endothelin-derived nitric oxide. J Clin Invest 85: 587\u2013590, 1990","journal-title":"J Clin Invest"},{"key":"126670_CR275","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0022-5347(17)37590-0","volume":"147","author":"CW Graham","year":"1992","unstructured":"Graham CW, Lynch JH, Djakiew D: Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J Urol 147: 1444\u20131447, 1992","journal-title":"J Urol"},{"key":"126670_CR276","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4615-2926-2_14","volume":"330","author":"D Djakiew","year":"1993","unstructured":"Djakiew D, Pflug B, Onoda M: Stromal-epithelial paracrine interactions in the neoplastic rat and human prostate. Adv Exp Med Biol 330: 185\u2013202, 1993","journal-title":"Adv Exp Med Biol"},{"key":"126670_CR277","first-page":"3304","volume":"51","author":"D Djakiew","year":"1991","unstructured":"Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH, Onoda M: Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoptastic epithelial cell line and stromal cells of the human prostate. Cancer Res 51: 3304\u20133310, 1991","journal-title":"Cancer Res"},{"key":"126670_CR278","first-page":"1416","volume":"53","author":"D Djakiew","year":"1993","unstructured":"Djakiew D, Pflug BR, Delsite R, Onoda M, Lynch JH, Arand G, Thompson EW: Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 53: 1416\u20131420, 1993","journal-title":"Cancer Res"},{"key":"126670_CR279","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1267::AID-CNCR15>3.0.CO;2-Z","volume":"78","author":"G Yang","year":"1996","unstructured":"Yang G, Wheeler TM, Kattan MW, Scardino PT, Thompson TC: Perincural invasion of prostate carcinoma cells is associated with reduced apoptotic index. Cancer 78: 1267\u20131271, 1996","journal-title":"Cancer"},{"key":"126670_CR280","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/S0021-9258(17)41999-5","volume":"269","author":"K Horigome","year":"1994","unstructured":"Horigome K, Bullock ED, Johnson EM Jr: Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 269: 2695\u20132702, 1994","journal-title":"J Biol Chem"},{"key":"126670_CR281","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nm1095-1040","volume":"1","author":"RC Smith","year":"1996","unstructured":"Smith RC, Litwin MS, Lu Y, Zetter BR: Identification of an endogenous inhibitor of prostatic carcinoma cell growth. Nature Med 1: 1040\u20131044, 1996","journal-title":"Nature Med"},{"key":"126670_CR282","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1055::AID-CNCR16>3.0.CO;2-1","volume":"78","author":"BG. Cipolla","year":"1996","unstructured":"Cipolla BG. Ziade J. Bansard JY, Moulinoux JP, Stacrman F, Quemener V, Lobel B, Guille F: Pretherapeutic erythrocyte polyamine spermine levels discriminate high risk relapsing patients with MI prostate carcinoma. Cancer 78: 1055\u20131065, 1996","journal-title":"Cancer"},{"key":"126670_CR283","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pros.2990240311","volume":"24","author":"LC Costello","year":"1994","unstructured":"Costello LC, Franklin RB: Effect of prolactin on the prostate. [Review]. Prostate 24: 162\u2013166, 1994","journal-title":"Prostate"},{"key":"126670_CR284","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<144::AID-CNCR24>3.0.CO;2-4","volume":"77","author":"T Janssen","year":"1996","unstructured":"Janssen T, Darro F, Petein M, Raviv G, Pasteels JL, Kiss R, Schulman CC: In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145 and PC3 models of the human prostate. Cancer 77: 144\u2013149, 1996","journal-title":"Cancer"},{"key":"126670_CR285","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0959-8049(95)00233-2","volume":"31A","author":"A Rana","year":"1995","unstructured":"Rana A, Habib FK, Halliday P, Ross M, Wild R, Elton RA, Chisholm GD: A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate [see comments]. Eur J Cancer 31A: 871\u2013875, 1995","journal-title":"Eur J Cancer"},{"key":"126670_CR286","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<717::AID-IJC1>3.0.CO;2-1","volume":"65","author":"J Heino","year":"1996","unstructured":"Heino J: Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation. Int J Cancer 65: 717\u2013722, 1996","journal-title":"Int J Cancer"},{"key":"126670_CR287","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/jcs.108.3.1165","volume":"108","author":"K Jewell","year":"1995","unstructured":"Jewell K, Kapron-Bras C, Jeevaratnam P, Dedhar S: Stimulation of tyrosine phosphorylation of distinct proteins in response to antibody-mediated ligation and clustering of alpha 3 and alpha 6 integrins. J Cell Sci 108: 1165\u20131174, 1995","journal-title":"J Cell Sci"},{"key":"126670_CR288","first-page":"167","volume":"145","author":"JD Knox","year":"1994","unstructured":"Knox JD, Cress AE, Clark V, Manriquez L, Affinito KS, Dalkin BL, Nagle RB: Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol 145: 167\u2013174, 1994","journal-title":"Am J Pathol"},{"key":"126670_CR289","first-page":"232","volume":"Suppl19","author":"RB Nagle","year":"1994","unstructured":"Nagle RB, Knox JD, Wolt C, Bowden GT, Cress AE: Adhesion molecules, extraccllular matrix, and proteases in prostate carcinoma. J Cell Biochem Suppl 19: 232\u2013237, 1994","journal-title":"J Cell Biochem"},{"key":"126670_CR290","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00690293","volume":"14","author":"AE Cress","year":"1995","unstructured":"Cress AE, Rabinovitz I, Zhu W, Nagle RB: The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev 14: 219\u2013228, 1995","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR291","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00690293","volume":"14","author":"AE Cress","year":"1995","unstructured":"Cress AE, Rabinovitz I, Zhu W, Nagle RB: The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. [Review]. Cancer Metastasis Rev 14: 219\u2013228, 1995","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR292","first-page":"1498","volume":"146","author":"RB Nagle","year":"1995","unstructured":"Nagle RB, Hao J, Knox JD, Dalkin BL, Clark V, Cress AE: Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol 146: 1498\u20131507, 1995","journal-title":"Am J Pathol"},{"key":"126670_CR293","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00118187","volume":"13","author":"I Rabinovitz","year":"1995","unstructured":"Rabinovitz I, Nagle RB, Cress AE: Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo. Clin Exp Metastasis 13: 481\u2013491, 1995","journal-title":"Clin Exp Metastasis"},{"key":"126670_CR294","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00132982","volume":"11","author":"S Dedhar","year":"1993","unstructured":"Dedhar S, Saulnier R, Nagle R, Overall CM: Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin Exp Metastasis 11: 391\u2013400, 1993","journal-title":"Clin Exp Metastasis"},{"key":"126670_CR295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj3060129","volume":"306","author":"M Coppolino","year":"1995","unstructured":"Coppolino M, Migliorini M, Argraves WS, Dedhar S: Identification of a novel form of the alpha 3 integrin subunit: covalent association with transferrin receptor. Biochem J 306: 129\u2013134, 1995","journal-title":"Biochem J"},{"key":"126670_CR296","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1073\/pnas.89.13.6197","volume":"89","author":"MC Rossi","year":"1992","unstructured":"Rossi MC, Zetter BR. Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci USA 89: 6197\u20137201, 1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"126670_CR297","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1862::AID-CNCR16>3.0.CO;2-Y","volume":"77","author":"MH Sokoloff","year":"1996","unstructured":"Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, de Kernion JB, Belldegrun AS: In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer 77: 1862\u20131872, 1996","journal-title":"Cancer"},{"key":"126670_CR298","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF01215981","volume":"119","author":"CM Witkowski","year":"1993","unstructured":"Witkowski CM, Rabinovitz I, Nagle RB, Affinito KS, Cress AE: Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines, J Cancer Res Clin Oncol 119: 637\u2013644, 1993","journal-title":"J Cancer Res Clin Oncol"},{"key":"126670_CR299","unstructured":"Paul R, Jarrard DF, Bussemakers MJ, Nguyen SH, Bova GS, Schalken JA, Isaacs WB: Loss of P-cadherin expression in prostate cancer. Eur Urol 30(52), 1996 (Abstract)"},{"key":"126670_CR300","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1101\/SQB.1994.059.01.075","volume":"59","author":"WB Isaacs","year":"1994","unstructured":"Isaacs WB, Bova GS, Morton RA, Busscmakers MJ, Brooks JD, Ewing CM: Genetic alterations in prostate cancer. [Review]. Cold Spring Harb Symp Quant Biol 59: 653\u2013659, 1994","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"126670_CR301","first-page":"5104","volume":"52","author":"R Umbas","year":"1992","unstructured":"Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaaes WB: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52: 5104\u20135109, 1992","journal-title":"Cancer Res"},{"key":"126670_CR302","first-page":"1375","volume":"148","author":"L Cheng","year":"1996","unstructured":"Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG: Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 148: 1375\u20131380, 1996","journal-title":"Am J Pathol"},{"key":"126670_CR303","first-page":"835","volume":"7","author":"JS Ross","year":"1994","unstructured":"Ross JS, Figge HL, Bui HX, del Rosario AD, Fisher HA, Nazeer T, Jennings TA, Ingle R, Kim DN: F-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade. DNA content pathologic stage, and clinical outcome. Mod Pathol 7: 835\u2013841, 1994","journal-title":"Mod Pathol"},{"key":"126670_CR304","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00689788","volume":"12","author":"LA Giroldi","year":"1993","unstructured":"Giroldi LA, Schalken JA: Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Rev 12: 29\u201337, 1993","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR305","first-page":"3929","volume":"54","author":"R. I. Umbas","year":"1994","unstructured":"Umbas R, Isaac WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oostcrhof GO, Debruync FM, Schalken JA: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54: 3929\u20133933, 1994","journal-title":"Cancer Res"},{"key":"126670_CR306","first-page":"2916","volume":"52","author":"MJ Bussemakers","year":"1992","unstructured":"Bussemakers MJ, Van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaaes JT, Takeichi M, Debruyne FM, Schalken JA: Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 52: 2916\u20132922, 1992","journal-title":"Cancer Res"},{"key":"126670_CR307","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00689788","volume":"12","author":"LA Giroldi","year":"1993","unstructured":"Giroldi LA, Schalken JA: Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. [Review], Cancer Metastasis Rev 12:29\u201337, 1993","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR308","first-page":"5195","volume":"55","author":"JR Graff","year":"1995","unstructured":"Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NF, Baylin SB: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195\u20135199, 1995","journal-title":"Cancer Res"},{"key":"126670_CR309","first-page":"339A","volume":"155","author":"JA Schalken","year":"1996","unstructured":"Schalken JA, Smit F, Bringuier PP, van Bokhoven A, Debruyne FM, Bussemakers MJ: The role of E-cadherin mutations in bladder and prostate cancer, is E-cadherin a classical suppressor gene? J Urol 155: 339A, 1996","journal-title":"J Urol"},{"key":"126670_CR310","first-page":"4813","volume":"55","author":"CM Ewing","year":"1995","unstructured":"Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB: Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. Cancer Res 55: 4813\u20134817, 1995","journal-title":"Cancer Res"},{"key":"126670_CR311","first-page":"11","volume":"1109","author":"W Birchmeier","year":"1994","unstructured":"Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1109: 11\u201326, 1994","journal-title":"Biochim Biophys Acta"},{"key":"126670_CR312","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1083\/jcb.127.6.2061","volume":"127","author":"J Hulsken","year":"1994","unstructured":"Hulsken J, Birchmeier W, Behrens J: E-cadherin and APC compete for the intraction with beta catenin and the cytoskeleton. J Cell Biol 127: 2061\u20132069, 1994","journal-title":"J Cell Biol"},{"key":"126670_CR313","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1006\/bbrc.1995.2015","volume":"212","author":"G Carruba","year":"1995","unstructured":"Carruba G, Miceli D, D'Amico D, Farruggio R, Comito L, Montesanti A, Polito L, Castagnetta LA: Sex steroids upregulate E-cadherin expression in hormone-responsive LNCaP human prostate cancer cells. Biochem Biophys Res Commun 212: 624\u2013631, 1995","journal-title":"Biochem Biophys Res Commun"},{"key":"126670_CR314","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/44.1.8543780","volume":"44","author":"F Prall","year":"1996","unstructured":"Prall F, Nollau P, Neumaier M, Haubeck HD, Drzeniek Z, Helmchen U, Loning T, Wagener C: CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and mycloid cells in a wide range of normal human tissues. J Histochem Cytochem 44: 35\u201341, 1996","journal-title":"J Histochem Cytochem"},{"key":"126670_CR315","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/S0021-9258(17)41918-1","volume":"269","author":"JT Hsich","year":"1994","unstructured":"Hsich JT, Lin SH: Androgen regulation of cell adhesion molecule gene expression in rat prostate during organ degeneration. C-CAM belongs to a class of androgen-repressed genes associated with enriched stem\/amplifying cell population after prolonged castration. J Biol Chem 269: 3711\u20133716, 1994","journal-title":"J Biol Chem"},{"key":"126670_CR316","first-page":"1215","volume":"55","author":"DI Kleinerman","year":"1995","unstructured":"Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT: Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res 55: 1215\u20131220, 1995","journal-title":"Cancer Res"},{"key":"126670_CR317","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/bj3110239","volume":"311","author":"SH Lin","year":"1995","unstructured":"Lin SH, Luo W, Earley K, Cheung P, Hixson DC: Structure and Iunction of C-CAMI: effects of the cytoplasmic domain on cell aggregation. Biochem J 311: 239\u2013245, 1995","journal-title":"Biochem J"},{"key":"126670_CR318","first-page":"190","volume":"55","author":"J-T Hsich","year":"1995","unstructured":"Hsich J-T, Luo W, Song W, Wang Y, Kleinerman DI, Van NT, Lin SH: Tumour suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res 55: 190\u2013197, 1995","journal-title":"Cancer Res"},{"key":"126670_CR319","first-page":"2831","volume":"55","author":"DI Kleinerman","year":"1995","unstructured":"Kleinerman DI, Zhang WW, Lin SH, Nguyen TV, von Eschenbach AC, Hsieh JT: Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. Cancer Res 55: 2831\u20132836, 1995","journal-title":"Cancer Res"},{"key":"126670_CR320","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0959-8049(94)00446-C","volume":"31A","author":"JM Wolff","year":"1995","unstructured":"Wolff JM, Stephenson RN, Chisholm GD, Habib FK: Levels of circulating intercellular adhesion molecule-1 in patients with metastatic cancer of the prostate and benign prostatic hyperplasia. Eur J Cancer 31A: 339\u2013341, 1995","journal-title":"Eur J Cancer"},{"key":"126670_CR321","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27\u201331, 1995","journal-title":"Nature Med"},{"key":"126670_CR322","first-page":"651","volume":"56","author":"VB Lokeshwar","year":"1996","unstructured":"Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL: Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 56: 651\u2013657, 1996","journal-title":"Cancer Res"},{"key":"126670_CR323","first-page":"339","volume":"22","author":"J Folkman","year":"1991","unstructured":"Folkman J, Hanahan D: Switch to the angiogenic phenotype during tumorigenesis, [Review]. Princess Takamatsu Symp 22: 339\u2013347, 1991","journal-title":"Princess Takamatsu Symp"},{"key":"126670_CR324","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1: 149\u2013153, 1995","journal-title":"Nature Med"},{"key":"126670_CR325","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-5347(01)67114-3","volume":"154","author":"LF Brown","year":"1995","unstructured":"Brown LF, Yeo KT, Berse B, Morgentaler A, Dvorak, HF, Rosen S: Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. J Urol 154: 576\u2013579, 1995","journal-title":"J Urol"},{"issue":"Suppl","key":"126670_CR326","first-page":"463A","volume":"155","author":"SY Moon","year":"1996","unstructured":"Moon SY, Yoon JH, Moon WC, Seo KK, Ki YJ: Role of angiogenesis and vascular endothelial growth factor in glandular hyperplasia of rat ventral prostate. J Urol 155(Suppl): 463A, 1996","journal-title":"J Urol"},{"issue":"Suppl","key":"126670_CR327","first-page":"603A","volume":"155","author":"N Bertrand","year":"1996","unstructured":"Bertrand N, Jonea F, Moro F, Soedrello S, Malavaud B, Cussenot O, Rischman P, Sarramon JP, Toulouse JP: In vitro regulation of VEGF expression in epithelial prostatic cells by testosterone. J Urol 155(Suppl): 603A, 1996","journal-title":"J Urol"},{"key":"126670_CR328","first-page":"4140","volume":"55","author":"MR Freeman","year":"1995","unstructured":"Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M: Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 55: 4140\u20134145, 1995","journal-title":"Cancer Res"},{"key":"126670_CR329","first-page":"1499","volume":"55","author":"J Vukanovic","year":"1995","unstructured":"Vukanovic J, Isaacs JT: Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res 55: 1499\u20131504, 1995","journal-title":"Cancer Res"},{"key":"126670_CR330","first-page":"4230","volume":"55","author":"C Chen","year":"1995","unstructured":"Chen C, Parangi S, Tolentino MJ, Folkman J: A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 55: 4230\u20134233, 1995","journal-title":"Cancer Res"},{"key":"126670_CR331","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pros.2990260503","volume":"26","author":"J Vukanovic","year":"1995","unstructured":"Vukanovic J, Hartley-Asp B, Isaacs JT: Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers. Prostate 26: 235\u2013246, 1995","journal-title":"Prostate"},{"key":"126670_CR332","first-page":"1833","volume":"53","author":"J Vukanovic","year":"1993","unstructured":"Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B, Isaacs JT: Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res 53: 1833\u20131837, 1993","journal-title":"Cancer Res"},{"key":"126670_CR333","first-page":"3517","volume":"55","author":"J Vukanovic","year":"1995","unstructured":"Vukanovic J, Isaacs JT: Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide. Cancer Res 55: 3517\u20133520, 1995","journal-title":"Cancer Res"},{"key":"126670_CR334","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/1097-0142(19950515)75:10<2545::AID-CNCR2820751022>3.0.CO;2-X","volume":"75","author":"JA Siegal","year":"1995","unstructured":"Siegal JA, Yu E, Brawer MK: Topography of neovascularity in human prostate carcinoma. Cancer 75: 2545\u20132551, 1995","journal-title":"Cancer"},{"key":"126670_CR335","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0090-4295(94)80173-8","volume":"44","author":"MC Hall","year":"1994","unstructured":"Hall MC, Troncoso P, Pollack A, Zhau HY, Zagars GK, Chung LW, von Eschenbach AC: Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 44: 869\u2013875, 1994","journal-title":"Urology"},{"key":"126670_CR336","first-page":"401","volume":"143","author":"N Weidner","year":"1993","unstructured":"Weidner N, Carroll PR, Flax J, Blumenteld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401\u2013409, 1993","journal-title":"Am J Pathol"},{"key":"126670_CR337","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO;2-6","volume":"73","author":"MK Brawer","year":"1994","unstructured":"Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA: Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73: 678\u2013687, 1994","journal-title":"Cancer"},{"key":"126670_CR338","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.1996.14.5.1626","volume":"14","author":"PJ Rosen","year":"1996","unstructured":"Rosen PJ, Mendoza EF, Landaw EM, Mondino B, Graves MC, McBride JH, Turcillo P, DeKernion J, Belldegrun A: Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy. J Clin Oncol 14: 1626\u20131636, 1996","journal-title":"J Clin Oncol"},{"key":"126670_CR339","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0142(19950801)76:3<453::AID-CNCR2820760316>3.0.CO;2-E","volume":"76","author":"NA Dawson","year":"1995","unstructured":"Dawson NA, Cooper MR, Figg WD, Headlee DJ, Thibault A, Bergan RC, Steinberg SM, Sausville EA, Myers CE, Sartor O: Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables. Cancer 76: 453\u2013462, 1995","journal-title":"Cancer"},{"key":"126670_CR340","first-page":"4957","volume":"55","author":"A Firsching","year":"1995","unstructured":"Firsching A, Nickel P, Mora P, Allolio B: Antiproliferative and angiostatic activity of suramin analogues. Cancer Res 55: 4957\u20134961, 1995","journal-title":"Cancer Res"},{"key":"126670_CR341","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/1097-0142(19951201)76:11<2304::AID-CNCR2820761119>3.0.CO;2-N","volume":"76","author":"GE Meyer","year":"1995","unstructured":"Meyer GE, Yu E, Siegal JA, Petteway JC, Blumenstein BA, Brawer ML: Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76: 2304\u20132311, 1995","journal-title":"Cancer"},{"key":"126670_CR342","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00689790","volume":"12","author":"JL Mohler","year":"1993","unstructured":"Mohler JL: Cellular motility and prostatic carcinoma metastases. [Review]. Cancer Metastasis Rev 12: 53\u201367, 1993","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR343","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00689789","volume":"12","author":"ME Stearns","year":"1993","unstructured":"Stearns ME, Stearns M: Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion. [Review]. Cancer Metastasis Rev 12: 39\u201352, 1993","journal-title":"Cancer Metastasis Rev"},{"key":"126670_CR344","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-5347(17)37291-9","volume":"147","author":"GM Doyle","year":"1992","unstructured":"Doyle GM, Sharief Y, Mohler JL: Prediction of metastatic potential by cancer cell motility in the Dunning R 3327 prostatic adenocarcinoma in vivo model. J Urol 147: 514\u2013518, 1992","journal-title":"J Urol"},{"key":"126670_CR345","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pros.2990200308","volume":"20","author":"KJ Pienta","year":"1992","unstructured":"Pienta KJ, Murphy BC, Isaacs WB, Isaacs JT, Coffey DS: Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motility. Prostate 20: 233\u2013241, 1992","journal-title":"Prostate"},{"key":"126670_CR346","first-page":"195","volume":"6","author":"ME Stearns","year":"1994","unstructured":"Stearns ME, Wang M: Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: offects of taxol. Oncol Res 6: 195\u2013201, 1994","journal-title":"Oncol Res"},{"key":"126670_CR347","first-page":"157","volume":"7","author":"ME Stearns","year":"1995","unstructured":"Stearns ME, Wang M, Stearns M: IL-10 blocks collagen IV invasion by \u2018invasion stimulating factor\u2019 activated PC-3 ML cells: upregulation of TIMP-1 expression. Oncol Res 7: 157\u2013163, 1995","journal-title":"Oncol Res"},{"key":"126670_CR348","first-page":"4493","volume":"53","author":"BL Lokeshwar","year":"1993","unstructured":"Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z: Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res 53: 4493\u20134498, 1993","journal-title":"Cancer Res"},{"key":"126670_CR349","first-page":"417","volume":"53","author":"WC Powell","year":"1993","unstructured":"Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT: Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 53: 417\u2013422, 1993","journal-title":"Cancer Res"},{"key":"126670_CR350","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF01613138","volume":"117","author":"MS Pajouh","year":"1991","unstructured":"Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT: Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 117: 144\u2013150, 1991","journal-title":"J Cancer Res Clin Oncol"},{"key":"126670_CR351","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1098-2744(199601)15:1<57::AID-MC8>3.0.CO;2-P","volume":"15","author":"JD Knox","year":"1996","unstructured":"Knox JD, Wolf C, McDaniel K, Clark V, Loriot M, Bowden GT, Nagle RB: Matrilysin expression in human prostate carcinoma. Mol Cardinog 15: 57\u201363, 1996","journal-title":"Mol Cardinog"},{"key":"126670_CR352","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/bjc.1994.336","volume":"70","author":"T Baker","year":"1994","unstructured":"Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J: Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer 70: 506\u2013512, 1994","journal-title":"Br J Cancer"},{"key":"126670_CR353","first-page":"114","volume":"147","author":"DW Hsu","year":"1995","unstructured":"Hsu DW, Efird JT, Hedley-Whyte ET: Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 147: 114\u2013123, 1995","journal-title":"Am J Pathol"},{"key":"126670_CR354","first-page":"2373","volume":"54","author":"A Achibarou","year":"1994","unstructured":"Achibarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D: Urokinase over-production results in increased skeletal metastasis by prostate cancer in vitro. Cancer Res 54: 2373\u20132377, 1994","journal-title":"Cancer Res"},{"key":"126670_CR355","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/pros.2990180303","volume":"18","author":"HN Keer","year":"1991","unstructured":"Keer HN, Gaylis FD, Kozlowski JM, Kwaan HC, Bauer KD, Sinha AA, Wilson MJ: Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior. Prostate 18: 201\u2013214, 1991","journal-title":"Prostate"},{"key":"126670_CR356","volume-title":"Ionic Channels of Excitable Membranes","author":"B Hille","year":"1992","unstructured":"Hille B: Ionic Channels of Excitable Membranes. Sunderland, Massachusetts: Sinauer Associates Inc. 1992"},{"key":"126670_CR357","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1016\/S0021-9258(18)98421-8","volume":"268","author":"M Cohen-Armon","year":"1993","unstructured":"Cohen-Armon M, Sokolovsky M: Evidence for involvement of the voltage-dependent Na+ channel gating in depolarization-induced activation of G-proteins. J Biol Chem 268: 9824\u20139838, 1993","journal-title":"J Biol Chem"},{"key":"126670_CR358","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jcp.1041620202","volume":"162","author":"KA Woodfork","year":"1995","unstructured":"Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS: Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol 162: 163\u2013171, 1995","journal-title":"J Cell Physiol"},{"key":"126670_CR359","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jcp.1041650121","volume":"165","author":"WF Wonderlin","year":"1995","unstructured":"Wonderlin WF, Woodfork KA, Strobl JS: Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 165: 177\u2013185, 1995","journal-title":"J Cell Physiol"},{"key":"126670_CR360","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bjc.1995.57","volume":"71","author":"S Kondo","year":"1995","unstructured":"Kondo S, Yin D, Morimura T, Kubo II, Nakatsu S, Takeuchi J: Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. Br J Cancer 71: 282\u2013289, 1995","journal-title":"Br J Cancer"},{"key":"126670_CR361","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-4652(199601)166:1<49::AID-JCP6>3.0.CO;2-G","volume":"166","author":"FM Van Dolah","year":"1996","unstructured":"Van Dolah FM, Ramsdell JS: Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1\/S and G2\/M transitions and prevents CDC2 kinase activation in GH4C1 cells. J Cell Physiol 166: 49\u201356, 1996","journal-title":"J Cell Physiol"},{"key":"126670_CR362","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-2478(94)00198-Z","volume":"44","author":"P Nagy","year":"1995","unstructured":"Nagy P, Panyi G, Jenei A, Bene L, Gaspar R Jr, Matko J, Damjanovich S: Ion-channel activities regulate transmembrane signaling in thymocyte apoptosis and T-cell activation. Immunol Lett 44: 91\u201395, 1995","journal-title":"Immunol Lett"},{"key":"126670_CR363","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1083\/jcb.122.5.1131","volume":"122","author":"A Arcangeli","year":"1993","unstructured":"Arcangeli A, Becchetti A, Mannini A, Mugnai G, De Filippi P, Tarone G, Del Bene MR, Barletta E, Wanke E, Olivotto M: Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J Cell Biol 122: 1131\u20131143, 1993","journal-title":"J Cell Biol"},{"key":"126670_CR364","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0092-8674(95)90121-3","volume":"83","author":"LL Isom","year":"1995","unstructured":"Isom LL, Ragsdale DS, De Jongh KS, Westenbrock RE, Reber BF, Scheuer T, Catterall WA: Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 83: 433\u2013442, 1995","journal-title":"Cell"},{"key":"126670_CR365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1098\/rspb.1992.0067","volume":"248","author":"A Becchetti","year":"1992","unstructured":"Becchetti A, Arcangeli A, Del Bene MR, Olivotto M, Wanke E: Response to fibroncetin-integrin interaction in leukaemia cells: delayed enhancing of a K+ current. Proc R Soc Lond B Biol Sci 248: 235\u2013240, 1992","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"126670_CR366","first-page":"1095","volume":"36","author":"MA Watsky","year":"1995","unstructured":"Watsky MA: Loss of keratocyte ion channels during wound healing in the rabbit cornea. Invest Ophthalmol Vis Sci 36: 1095\u20131099, 1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"126670_CR367","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1172\/JCI117144","volume":"93","author":"A Schwab","year":"1994","unstructured":"Schwab A, Wojnowski L, Gabriel K, Oberleithner H: Oscillating activity of a Ca(2+)-sensitive K+ channel. A prerequisite for migration of transformed Madin-Darby canine kidney focus cells. J Clin Invest 93: 1631\u20131636, 1994","journal-title":"J Clin Invest"},{"key":"126670_CR368","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/j.1460-2075.1995.tb06974.x","volume":"14","author":"K Bokvist","year":"1995","unstructured":"Bokvist K, Eliasson L, Ammala C, Renstrom E, Rorsman P: Co-localization of L-type Ca2+ channels and insulincontaining secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B-cells. EMBO J 14: 50\u201357, 1995","journal-title":"EMBO J"},{"key":"126670_CR369","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/379451a0","volume":"379","author":"ZH Sheng","year":"1996","unstructured":"Sheng ZH, Rettig J, Cook T, Catterall WA: Calcium de pendent interaction of N-type calcium channels with the synaptic core complex. Nature 379: 451\u2013454, 1996","journal-title":"Nature"},{"key":"126670_CR370","first-page":"1231","volume":"13","author":"JJ Pancrazio","year":"1993","unstructured":"Pancrazio JJ, Tabbara IA, Kim YI: Voltage-activated K+ conductance and cell proliferation in small-cell lung cancer. Anticancer Res 13: 1231\u20131234, 1993","journal-title":"Anticancer Res"},{"key":"126670_CR371","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1113\/jphysiol.1995.sp020562","volume":"482","author":"CF Higgins","year":"1995","unstructured":"Higgins CF: Volume-activated chloride currents associated with the multidrug resistance P-glycoprotein. [Review]. J Physiol (Lond) 482: 31S\u201336S, 1995","journal-title":"J Physiol (Lond)"},{"key":"126670_CR372","first-page":"3736","volume":"46","author":"N Yamashita","year":"1987","unstructured":"Yamashita N, Hamada H, Tsuruo T, Ogata E: Enhancement of voltage-gated Na+ channel current associated with multidrug resistance in human leukemia cells. Cancer Res 46: 3736\u20133741, 1987","journal-title":"Cancer Res"},{"key":"126670_CR373","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0896-6273(92)90083-P","volume":"8","author":"E Neher","year":"1992","unstructured":"Neher E: Nobel lecture. Ion channels for communication between and within cells. [Review]. Neuron 8: 605\u2013612, 1992","journal-title":"Neuron"},{"key":"126670_CR374","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0014-5793(95)00772-2","volume":"369","author":"JA Grimes","year":"1995","unstructured":"Grimes JA, Fraser SP, Stephens GJ, Downing JE, Laniado ME, Foster CS, Abel PD, Djamgoz MB, Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett 369: 290\u2013294, 1995","journal-title":"FEBS Lett"},{"key":"126670_CR375","unstructured":"Laniado ME, Lalani E-N, Fraser SP, Grimes JA, Bhangal G, Djamgoz MB, Abel PD: Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol 1997 (in press)"},{"issue":"52","key":"126670_CR376","first-page":"434","volume":"30","author":"ME Laniado","year":"1996","unstructured":"Laniado ME, Lalani E-N, Fraser SP, Djamgoz MB, Abel PD: Outward voltage-activated K+ currents distinguish LNCaP and PC-3 cell lines. Eur Urol 30(52): 434, 1996 (Abstract)","journal-title":"Eur Urol"},{"key":"126670_CR377","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000217878","volume":"15","author":"AA Marino","year":"1994","unstructured":"Marino AA, Iliev IG, Schwalke MA, Gonzalez E, Marler KC, Flanagan CA: Association between cell membrane potential and breast cancer. Tumour Biol 15: 82\u201389, 1994","journal-title":"Tumour Biol"},{"key":"126670_CR378","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jcp.1041650121","volume":"165","author":"WF Wonderlin","year":"1995","unstructured":"Wonderlin WF, Woodfork KA, Strobl JS: Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 165: 177\u2013185, 1995","journal-title":"J Cell Physiol"},{"key":"126670_CR379","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/BF00386179","volume":"430","author":"A Schwab","year":"1995","unstructured":"Schwab A, Gabriel K, Finsterwalder F, Folprecht G, Greger R, Kramer A, Oberleithner H: Polarized ion transport during migration of transformed Madin-Darby canine kidney cells. Pflugers Arch 430: 802\u2013807, 1995","journal-title":"Pflugers Arch"},{"key":"126670_CR380","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pros.2990130203","volume":"13","author":"N Kyprianou","year":"1988","unstructured":"Kyprianou N, English HF, Isaacs JT: Activation of a Ca\u2212+-Mg++-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 13: 103\u2013118, 1988","journal-title":"Prostate"},{"key":"126670_CR381","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pros.2990170302","volume":"17","author":"P Martikainen","year":"1990","unstructured":"Martikainen P, Isaacs JT: Role of calcium in the programmed death of rat prostatic glandular cells. Prostate 17: 175\u2013188, 1990","journal-title":"Prostate"},{"key":"126670_CR382","first-page":"6167","volume":"54","author":"Y Furuya","year":"1994","unstructured":"Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT: The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 54: 6167\u20136175, 1994","journal-title":"Cancer Res"},{"key":"126670_CR383","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pros.2990130204","volume":"13","author":"J Connor","year":"1988","unstructured":"Connor J, Sawezuk IS, Benson MC, Tomashefsky P, O'Toole KM, Olsson CA, Buttyan R: Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. Prostate 13: 119\u2013130, 1988","journal-title":"Prostate"},{"issue":"Suppl","key":"126670_CR384","first-page":"527","volume":"155","author":"T McDonnell","year":"1996","unstructured":"McDonnell T, von Eschenbach A, Marin M, Fernandez A, Westin P, Shi-Ming T, Brisbay S, Bick R, Buju L, McConkey D: Bel-2 confers resistance to cell death induction by androgen-ablation and chemotherapy in prostate cancer cells. J Urol 155(Suppl): 527, 1996","journal-title":"J Urol"},{"key":"126670_CR385","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0006-291X(91)91338-D","volume":"179","author":"J Steinsapir","year":"1991","unstructured":"Steinsapir J, Socci R, Reinach P: Effects of androgen on intracellular calcium of LNCaP cells. Biochem Biophys Commun 179: 90\u201396, 1991","journal-title":"Biochem Biophys Commun"},{"key":"126670_CR386","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pros.2990190404","volume":"19","author":"S Batra","year":"1991","unstructured":"Batra S, Popper LD, Hartley-Asp B: Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells. Prostate 19: 299\u2013311, 1991","journal-title":"Prostate"},{"key":"126670_CR387","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/excr.1995.1146","volume":"218","author":"MP Peppelenbosch","year":"1995","unstructured":"Peppelenbosch MP, Tertoolen LG, De Laat SW, Zivkovie D: Ionic responses to epidermal growth factor in zebrafish cells. Exp Cell Res 218: 183\u2013188, 1995","journal-title":"Exp Cell Res"},{"key":"126670_CR388","doi-asserted-by":"crossref","first-page":"25483","DOI":"10.1016\/S0021-9258(18)47276-6","volume":"26","author":"RP Misra","year":"1994","unstructured":"Misra RP, Bonni A, Miranti CK, Rivera VM, Sheng M, Greenberg ME: L-type voltage-sensitive calcium channel activation stimulates gene expression by a serum response factor-dependent pathway. J Biol Chem 26: 25483\u201325493, 1994","journal-title":"J Biol Chem"},{"key":"126670_CR389","doi-asserted-by":"crossref","first-page":"C442","DOI":"10.1152\/ajpcell.1988.255.4.C442","volume":"255","author":"H Matsunaga","year":"1988","unstructured":"Matsunaga H, Nishimoto I, Kojima I, Yamashita N, Kurokawa K, Ogata E: Activation of a calcium-permeable cation channel by insulin-like growth factor II in BALB\/c 3T3 cells. Am J Physiol 255: C442\u2013446, 1988","journal-title":"Am J Physiol"},{"key":"126670_CR390","doi-asserted-by":"crossref","first-page":"13099","DOI":"10.1074\/jbc.270.22.13099","volume":"270","author":"M Kanzaki","year":"1995","unstructured":"Kanzaki M, Shibata H, Morgami H, Kojima I: Expression of calcium-permeable eation channel CD20 accelerates progression through the G1 phase in Balb\/c 3T3 cells. J Biol Chem 270: 13099\u201313104, 1995","journal-title":"J Biol Chem"},{"key":"126670_CR391","doi-asserted-by":"crossref","first-page":"31183","DOI":"10.1016\/S0021-9258(18)47407-8","volume":"269","author":"Y Huang","year":"1994","unstructured":"Huang Y, Rane SG: Potassium channel induction by the Ras\/Raf signal transduction cascade. J Biol Chem 269: 31183\u201331189, 1994","journal-title":"J Biol Chem"},{"key":"126670_CR392","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.127.1.117","volume":"127","author":"MJ Brown","year":"1994","unstructured":"Brown MJ, Loew LM: Electric field-directed fibroblast locomotion involves cell surface molecular reorganization and is calcium independent. J Cell Biol 127: 117\u2013128, 1994","journal-title":"J Cell Biol"},{"key":"126670_CR393","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0022-5347(17)39093-6","volume":"142","author":"HB Carter","year":"1989","unstructured":"Carter HB, Partin AW, Coffey DS: Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface charge. J Urol 142: 1338\u20131341, 1989","journal-title":"J Urol"},{"key":"126670_CR394","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-5347(17)41521-7","volume":"140","author":"HB Carter","year":"1988","unstructured":"Carter HB, Coffey DS: Cell surface charge in predicting metastatic potential of aspirated cells from the Dunning rat prostatic adenocarcinoma model. J Urol 140: 173\u2013175, 1988","journal-title":"J Urol"},{"key":"126670_CR395","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0022-5347(17)53345-5","volume":"128","author":"JL Ware","year":"1982","unstructured":"Ware JL, Paulson DF, Mickey GH, Webb KS: Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. J Urol 128: 1064\u20131067, 1982","journal-title":"J Urol"},{"key":"126670_CR396","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-5347(17)39903-2","volume":"143","author":"ER Sherwood","year":"1990","unstructured":"Sherwood ER, Berg LA, Mitchell NJ, McNeal JE, Kozlowski JM, Lee C: Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol 143: 167\u2013171, 1990","journal-title":"J Urol"},{"key":"126670_CR397","first-page":"281","volume":"47","author":"RB Nagle","year":"1987","unstructured":"Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A: Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 47: 281\u2013286, 1987","journal-title":"Cancer Res"},{"key":"126670_CR398","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1089\/hum.1995.6.11-1417","volume":"6","author":"S Pang","year":"1995","unstructured":"Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M, Tso CL, deKernion JB, Belldegrun AS: Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Human Gene Therapy 6: 1417\u20131426, 1995","journal-title":"Human Gene Therapy"},{"key":"126670_CR399","first-page":"1807","volume":"54","author":"RS Israeli","year":"1994","unstructured":"Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD: Expression of the prostate-specific membrane antigen. Cancer Res 54: 1807\u20131811, 1994","journal-title":"Cancer Res"},{"key":"126670_CR400","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00157682","volume":"14","author":"PJ Kostenuik","year":"1996","unstructured":"Kostenuik PJ, Sanchez-Sweatman O, Orr FW, Singh G: Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the \u03b12\u03b21 integrin. Clin Exp Metastasis 14: 19\u201326, 1996","journal-title":"Clin Exp Metastasis"},{"key":"126670_CR401","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1016\/S0021-9258(19)37047-4","volume":"267","author":"S Dedhar","year":"1992","unstructured":"Dedhar S, Jewell K, Rojiani M, Gray V: The receptor for the basement membrane glycoprotein entactin is the integrin alpha 3\/beta 1. J Biol Chem 267: 18908\u201318914, 1992","journal-title":"J Biol Chem"},{"key":"126670_CR402","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pros.2990260406","volume":"26","author":"OW Rokhlin","year":"1995","unstructured":"Rokhlin OW, Cohen MB: Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate 26: 205\u2013212, 1995","journal-title":"Prostate"},{"key":"126670_CR403","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-5347(17)42397-4","volume":"139","author":"K Fan","year":"1988","unstructured":"Fan K: Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefuiness of P21 protein as a predictor for bone metastasis. J Urol 139: 318\u2013322, 1988","journal-title":"J Urol"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005792206377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005792206377\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005792206377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:57:19Z","timestamp":1750960639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005792206377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":403,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["126670"],"URL":"https:\/\/doi.org\/10.1023\/a:1005792206377","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"type":"print","value":"0167-7659"},{"type":"electronic","value":"1573-7233"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}